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Abstract 
 
Male fertility has been declining over the past 50 years, vindicating demand for 
further research into the aetiological agent(s) responsible for this reduction in sperm 
count and quality. It is suggested that modern lifestyle factors including diet & 
sedentary lifestyle are culpable. Veganism has gained recent popularity by those 
conscious of ethical food sourcing and the impact of the meat industry upon the 
climate. In addition to these environmental benefits, adoption of a vegan diet also 
confers health benefits.  There have been associations between a plant-based diet 
and reduced risk of prediabetes and type 2 diabetes and reduced body mass index 
(BMI). Abnormal BMI is already well established to have negative effects on 
reproductive health. However, a lack of research into the effect of vegan diet on 
sperm methylation is yet to be explored. 
Male volunteers aged 22-40 years of age were recruited from the Manchester area, 
in reply to adverts placed around the university campus and through social media. 
Participants provided semen samples via masturbation and completed a food 
frequency questionnaire including questions regarding lifestyle, diet and biometrics. 
Participants were separated into cohorts according to self-reported dietary 
subscription. Omnivorous (n=5) and vegan (n=5). Sperm progressive motility, 
concentration, total sperm count, volume, pH and vitality were all measured. Sperm 
cells were isolated from semen via density gradient centrifugation; DNA was 
extracted from the sperm and an ELISA-based assay to assess sperm global 
methylation status was performed.  
Means of sperm parameters were compared via unpaired t-tests for the two dietary 
cohorts, as were means of the global methylation data for the two dietary cohorts. 
Biometrics & Lifestyle factors were evaluated as potential confounding factors via 
unpaired t-tests and Fisher’s contingency test. None were significant and therefore 
did not need to be controlled for. All data collected were also pooled into a combined 
cohort, and correlational analyses and linear regression performed to identify any 
associations between sperm parameters and global methylation, biostatistics & 
lifestyle factors and global methylation, sperm parameters and biostatistics & 
lifestyle factors, and interactions between sperm parameters all within the combined 
cohort.  
Statistically significant positive correlations were observed between combined 
cohort sperm progressive motility and concentration (r=0.7766, p=0.0082**) and 
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sperm motility and vitality (r=0.6535, p=0.0404*). No other statistically significant 
correlations were identified in the analysis of this study. 
The key aim of this pilot study was to determine whether subscription to an 
omnivorous or vegan diet has any significant effect on the methylation signature and 
quality of human sperm DNA. No such relationship was demonstrated in the results 
of this study, with no significant differences in sperm parameters or sperm DNA 
global methylation between omnivorous and vegan diets. This research alone 
suggests that subscription to an omnivorous or vegan diet has no bearing on the 
quality or methylation level of sperm DNA. Moving forward, further research should 
be carried out within a larger population to confirm these findings. 
 1 
1.0 Introduction  
1.1 Male Factor Infertility 
 
Recent reports on declining male fertility have emphasized a demand for further 
research into the aetiologies behind this reduction in sperm count and quality 
(Stephen et al, 2006; Levine et al, 2017; Sengupta et al, 2018). This decrease in 
male fertility is possibly attributed to modern lifestyle factors, such as diet, smoking 
tobacco and drinking alcohol, sedentary behaviour, and the rise in health conditions 
such as obesity and diabetes (Magnusdottir et al, 2005; Virtanen et al, 2017). 
In their systematic review and meta-regression analysis, Levine and colleagues 
reported an annual percentage decrease in sperm counts of 1.4%, an overall 
decrease of 52.4% in sperm count from 1973-2011 in males from Western countries 
unselected by fertility status (Levine et al, 2017). Comparably, Sengupta et al, 
(2018) reported a 32.5% decrease in mean sperm concentrations of European 
males over a 50-year period. 
Male factor infertility is a complex, multifactorial disorder, compartmentalised into 
congenital, acquired, and idiopathic factors, currently affecting approximately 7% of 
the male population; with as many as 2% displaying sub-optimal sperm parameters 
(Kumar and Singh, 2015; Krausz and Riera-Escamilla, 2018). Congenital factors 
include both primary and secondary hypogonadism such as anorchia (absence of 
one or both testes), cryptorchidism (where one or both testicles fail to descend) and 
genetic abnormalities such as Klinefelter’s syndrome and Prader-Willi syndrome. 
Acquired factors include testicular torsion, varicocele, erectile dysfunction and use 
of anabolic steroids (Ferlin et al, 2007; Masson and Brannigan, 2014; Osta et al, 
2016; Carroll, 2019).  
Idiopathic infertility accounts for ~40% of male factor infertilities (MFI), and relates 
to the aetiology of the infertility remaining unidentified following a full work-up 
including semen analysis and investigation of the ovulatory system and fallopian 
tubes of the female (Krausz et al, 2018). In the case of idiopathic infertility, where 
current routine investigations are insufficient to identify the cause, it is suggested 
that the infertility may be attributed to molecular, genetic or epigenetic changes in 
the individual (O’Flynn-O’Brien et al, 2010).  
Idiopathic infertility is diagnosed in 15-30% of couples (Quaas and Dokras, 2008). 
In some cases, aberrant epigenetics may be the cause. Aberrant histone 
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modifications have been described in patients with consistently poor embryo 
development in embryos derived from In Vitro Fertilisation (IVF) (Hammoud et al, 
2011; Aston et al, 2012). Sperm selected in the IVF clinic for Intracytoplasmic Sperm 
Injection (ICSI) based upon normozoospermic parameters have been shown to 
have aberrant methylation status and subsequent imprinting disorders (section 1.3) 
(Lazaraviciute et al, 2014). The ICSI-conceived offspring had higher rates of 
congenital abnormalities, despite the normozoospermic classification of sperm 
selected (Lazaraviciute et al, 2014).  
 
1.2 Diet & Fertility  
 
There are increasing numbers of individuals committing to a vegan lifestyle with 
1.16% (600,000) of the UK population currently identify as vegan – quadrupling 
since 2014 at 0.25% of the UK population (The Vegan Society, 2018). Furthermore, 
this increase in demand of vegan alternatives has led to the transition of veganism 
from a niche dietary trend into the mainstream, prompting subsequent investment 
into animal free-alternatives via the food industry; thereby creating wider availability 
of vegan food, allowing a ‘domino effect’ of vegan converts, numbers of which are 
projected to continue increasing (The Vegan Society, 2018). 
A plethora of preventative and therapeutic health effects of a vegan versus a more 
traditional, non-restrictive omnivorous diet has garnered much attention in recent 
research. Chen et al (2018) demonstrated an association between subscription to a 
plant-based diet and reduced risk of prediabetes and type 2 diabetes, in addition to 
reduced longitudinal insulin resistance. Spencer et al (2003) demonstrated an 
association between reduced body mass index (BMI) and reduced obesity levels 
compared to diets inclusive of particularly meat. A vegan diet has also been shown 
to reduce levels of low-density-lipoprotein (LDL); a risk factor in the development of 
atherosclerotic plaques, when compared to an omnivorous cohort (p=0.034) 
(Vinagre et al, 2013).  
However, there is a lack of research into the effect of vegan diet on male factor 
infertility. Chavarro et al (2008) investigated the effects of isoflavone phytoestrogens 
present in soya products; widely consumed as dairy alternatives amongst those 
following a vegan diet, upon semen parameters, the results demonstrated those 
with higher consumption of foods containing soya and soya isoflavones had 
41x106/ml less sperm than those who consumed no soya-containing foods. The 
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lower production of sperm is speculated to be in part, due to the phytoestrogen 
content, which may interfere in the regulation of the hypothalamic-pituitary-gonadal 
(HPG) axis responsible for the control of reproductive functions including 
spermatogenesis in males (Cederroth et al, 2012). 
Afeiche et al (2013) demonstrated that a diet consisting of dairy (absent from vegan 
diets) had a negative impact upon sperm morphology. Murine models have 
demonstrated a 25% reduction in epididymal sperm counts in mice fed a high-
phytoestrogen diet when compared to mice fed a low-phytoestrogen diet (significant 
at p=0.0022), in addition to a 21% reduction in litter size in the high-phytoestrogen 
diet group (Cederroth et al, 2010). 
  
1.3  Epigenetics  
 
In 1942, Conrad Waddington coined the phrase ‘Epigenetics’ (“epi”= in addition to); 
now  an umbrella term for what is widely accepted as heritable variances in genome 
function and phenotype that occur in the absence of DNA sequence alterations. 
Epigenetic mechanisms are responsible for necessary biological processes, such 
as X inactivation, development, and repression of transposable elements within the 
genome, providing its stability.  
Imprinting is an epigenetic mechanism characterised in mammals, occurring in <1% 
mammalian genes (Wilkinson et al, 2007). However, imprinting has also been 
documented in Sciaridae and Coccidae (invertebrate arthropods) (Barlow and 
Bartolomei, 2014) and is controlled via  methylation or histone modifications at 
nearby imprinting centres (IC). Imprinting limits the phenotypic expression of a gene 
to either the maternal or paternal allele (monoallelic expression) and is often referred 
to as ‘parent-of-origin inheritance’. For example, insulin-like growth factor II (IGF-2) 
necessary in embryonic development, is expressed paternally, and controlled by the 
imprinting centre 1 (IC1) (Barlow and Bartolomei, 2014; Genetics Home Reference, 
2019).  
Loss of methylation/histone modifications at the IC1 responsible for the appropriate 
control of IGF-2 expression and subsequent bi-allelic expression has been 
implicated in cancers and Beckwith-Wiedemann syndrome; characterised by 
overgrowth  (Genetics Home Reference, 2019). 
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Epigenetic modifications include post-translational histone modifications such as 
histone acetylation; the addition of a negatively charged acetyl group (CH3CO) to a 
lysine residue on a histone tail, via action of histone acetyltransferase enzymes 
(HAT), thus relaxing the histone structure, allowing active transcription of 
euchromatin (transcriptionally active lightly packed chromatin) of which, 92% of the 
genome is composed (International Human Genome Sequencing Consortium, 
2004). Histone de-acetyltransferase enzymes remove the acetyl group, thereby 
condensing the chromatin, rendering it transcriptionally inactive heterochromatin 
(transcriptionally inactive densely packed chromatin) (Error! Not a valid bookmark 
self-reference.).  
 
 
 
 
 
 
 
 
 
 
 
 
 
1.3.1 Methylation 
 
Methylation occurs throughout the genome and is a vital process in ensuring tissue-
specific expression/repression of appropriate genes. Methylation is also critical 
during embryonic development in ensuring appropriate imprinting (section 1.3). 
Methylation of a 5’-cytosine-phosphate-guanine-3’ site (CpG) (a cytosine-guanine 
dinucleotide in the 5’ direction, separated by the phosphate backbone of the DNA 
Figure 1. Summary of epigenetic mechanisms (Source: Rajender et al, 2011:64). 
 
 5 
helical structure) via the addition of a methyl group (CH3) to the 5th carbon in a 
cytosine pyrimidine ring, within a CpG site, forming 5-methylcytosine via covalent 
bonding through the action of the DNA-Methyltransferase enzyme family (DNMT). 
DNMT-3a and DNMT-3b control de novo methylation. DNMT-1 maintains these 5-
methylcytosine patterns through subsequent cell divisions (Okano et al, 1999; Gujar 
et al, 2019). 
Initiation of transcription occurs in promoter regions located at the 5’ end of genes. 
Promotor regions are often rich in CpG dinucleotides and are subsequently termed 
CpG islands (CGI) (Khambata-Ford et al, 2003). Should methylation of a CpG site 
within the promoter region of a gene occur, the gene would become transcriptionally 
silent, or, ‘off’ (Jones, 2012). 
Methylation is essential to life, as demonstrated by Li et al (1992) blastocyst-derived 
embryonic stem cells (ESC) without DNMTs are not viable past ~10 days’ 
development. 
The sum of deoxyribonucleic acid (DNA) methylation modifications within the 
genome is termed the methylome, which itself can display vast variation between 
cell types. 
 
 
 
 
 
 
 
 
 
 
 
 
 
H 
O 
N 
NH2 
N 
CH3 
H 
O 
N 
NH2 
N 
cytosine 5’-methylcytosine 
S-adenosylmethionine 
(SAM) 
S-adenosyl-L-homocysteine  
(SAH) 
DNA methyltransferase enzyme 
(DNMT) 
Figure 2. Schematic showing skeletal structure of cytosine and 5’-methylcytosine. S-adenosylmethionine acts as 
the methyl group donor, producing S-adenosyl-L-homocysteine as a by-product of the reaction. The reaction is 
catalysed by DNA methyltransferase enzymes. Adapted from source: Gibney and Nolan, 2010). 
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1.3.1.1 Methylation in Sperm 
 
Sperm display a vastly different methylation signature to that of somatic cell DNA 
(therefore the methylome of the sperm only, is of interest in this particular research).  
Sperm undergo transient epigenetic alterations throughout the stages of 
spermatogenesis (the production of sperm) including de novo methylation, 
demethylation and Histone 3 (H3) and Histone 4 (H4) (both implicated in chromatin 
structure) lysine residue acetylation and deacetylation. (Oakes et al, 2007; Stuppia 
et al, 2015).  
It is important to note that mature sperm are a relatively hypermethylated cell type 
(Popp et al, 2010); approximately twice as methylated as the oocyte, with 40% and 
89.4% global methylation respectively for the two cell types (Kobayashi et al, 2012).  
Spermatogenesis occurs in the basal lamina of the seminiferous tubules in the 
testis, beginning at puberty and under ‘normal’ circumstances will continue 
throughout the male’s adult life. 
 The process of spermatogenesis occurs over approximately 70 days (Kretser, 
2000). Spermatogonia (primary cells) replicate via mitosis into primary 
spermatocytes, proceeding to meiosis I where crossover of homologous 
chromosomes occurs. At the conclusion of meiosis I these cells are known as 
spermatocytes and these divide again via meiosis II to produce spermatids (haploid 
round cells). Finally, spermatids undergo spermiogenesis, the process of 
specialisation of the round cell spermatid to a flagellated cell, where the 
development of the acrosome, tail and increased nuclear condensation occurs to 
produce elongated sperm. Though spermatogenesis is over at this stage these 
sperm are immotile and must further maturate in the epididymis (Gadea et al, 2013). 
The epididymis is responsible for the storage, maturation and transportation of the 
sperm produced in the testis to the vas deferens, whereby the mature sperm are 
prepared for ejaculation. This maturation and passage through the epididymis (~2 
weeks) is where sperm are subjected to essential functional and morphological 
changes including the modification of chromatin. Sperm gain motility and the 
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capacity to fertilise an oocyte during this process (Sullivan and Mieusset, 2016; 
Zhou et al, 2018).  
In terms of infertility, there is abundant evidence that epigenetics play a pivotal role. 
Many studies have linked disparities in methylation with aberrant sperm 
characteristics and infertile phenotypes (Montjean et al, 2015; Urdinguio et al, 2015).  
However, there appears to be an inability within the field to agree whether abnormal 
sperm parameters are associated with hyper- or hypo- methylation. 
Montjean et al (2015) found that oligozoospermic (0.2-15x106/ml) and 
asthenozoospermic (<20% progressively motile) males had significantly lower levels 
of mean global sperm methylation (hypomethylation) than normozoospermic males. 
Furthermore, those with elevated fragmentation (>30% sperm DNA denaturation 
index) also displayed significantly lower levels of mean global sperm methylation 
than those with ‘normal’ levels of sperm fragmentation. 
Conversely, Houshdaran et al (2007) demonstrated significantly higher levels of 
methylation (hypermethylation) in sperm collected from males attending a fertility 
clinic.  
Marques et al (2008) demonstrated aberrant methylation of imprinted genes H19 
and MEST in individuals with sperm counts of <10x106/ml.  
The methylome of sperm from a single ejaculate is highly variable. Jenkins et al 
(2014) investigated intra-individual methylation status of fractioned sperm. 
Following density gradient centrifugation, a technique used within the andrology lab 
to separate what are considered poorer sperm retained within the upper layer (35% 
density) from the bottom layer (90% density) containing high quality sperm (see 
section 2.5.3.2 for more on density gradient centrifugation). It was demonstrated 
that the poorer quality sperm exhibited a significantly more heterogenous 
methylation profile than the higher quality sperm (p=0.0083).  
In addition to its variability, the sperm methylome responds to environmental factors. 
Denham et al (2015) demonstrated that global sperm methylation levels were 
modifiable by a 3-month period of exercise, compared to controls where global 
sperm DNA methylation levels remained constant (4.09%), the exercise group saw 
significant demethylation in sperm DNA (-6.63%) (p=0.006).  
Low levels of sperm methylation (hypomethylation) have been implicated in poor 
assisted reproductive outcomes. Benchaib et al (2005) observed a disparity of 
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33.3% pregnancy rate for those with >555 arbitrary units of methylation (normal 
methylation) compared to just 8.3% pregnancy rate for those with <555 arbitrary 
units of methylation (hypomethylated). Interestingly, fertilization rate and quality of 
embryos were unaffected by methylation level of the sperm. This could be due to 
the intra-sample heterogeneity of the methylome.  Bahreinian et al (2015) 
demonstrated a significantly lower mean percentage DNA methylation in men with 
varicocele compared with fertile individuals. 
The number of genes involved in the careful coordination of spermatogenesis are 
perhaps somewhere in the thousands. However, these have not all been well 
characterised.  
In terms of individual genes, deleted in azoospermia-like (DAZL) is a gene within 
the deleted in azoospermia (DAZ) gene cluster located on the Y chromosome. DAZL 
is an important candidate gene for methylation studies as its role is essential to 
spermatogenesis and is subsequently hypomethylated in healthy individuals. Any 
hypermethylation of DAZL would suggest poor spermatogenesis leading to 
azoospermia (low/absent sperm in ejaculate) (Zhang et al, 2016).  
DAZL encodes an RNA binding protein essential to spermatocyte meiosis, a key 
step in spermatogenesis (Niu et al, 2014).  
Aberrant DAZL methylation has been observed in oligoasthenoteratozoospermic 
(OAT)  individuals (Navarro-Costa et al, 2010). Loss of genes within the DAZ cluster 
results in azoospermia and oligospermia (Reijo et al, 1995). Furthermore, those with 
azoospermia possess fewer transcripts of the DAZL gene within the testis in contrast 
to normozoospermic individuals (Lin et al, 2001).  
Methylenetetrahydrofolate reductase (MTHFR) codes for an enzyme of the same 
name, essential to folate (vitamin B9) metabolism by conversion of 5,10-
methylenetetrahydrofolate reductase to 5-methyltetrahydrofolate. Part of the 
process of the regeneration of homocysteine to methionine – an amino acid crucial 
in the production of S-adenosyl-methionine – the methyl group donor critical to the 
methylation of DNA (Genetics Home Reference, 2017). Any disruption of the 
regulation of MTHFR can have downstream implications and subsequently result in 
the hypomethylation of DNA.  
Wu et al (2010) reported MTHFR promotor region hypermethylation in the sperm of 
41 out of 94 men with idiopathic infertility.  Similarly, Karaca et al (2017) reported an 
association between MTHFR promotor region hypermethylation and increased risk 
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of infertility. This suggests that MTHFR plays an important role in spermatogenesis 
and is an important candidate gene in the investigation of idiopathic infertility.  
 
 
1.3.2  Dietary Compounds Involved in the Control of Methylation 
 
1.3.2.1 Vitamin B12 (Cobalamin) 
 
Vitamin B12 is a crucial nutrient, aiding in many biochemical processes such as 
erythropoiesis, DNA synthesis, synthesis of myelin, and is critical in the SAM cycle 
(S-adenosylmethionine-cycle) as a co-factor for the re-methylation of homocysteine 
to methionine which then combines with adenosine triphosphate to form S-
adenosylmethionine; the methyl group donor involved in the methylation process 
(Figure 3). 
 
 
 
 
 
 
 
 
 
 
 
 
Therefore, a deficiency in the vitamin can lead to hyperhomocysteinemia (high 
homocysteine levels) due to the lack of methionine available to bind. 
Hyperhomocysteinemia can have a plethora of health implications as an 
independent risk factor in the development of disease, including Alzheimer’s and 
S-Adenosylhomocysteine 
(SAH) 
Homocysteine 
S-adenosylmethionine 
(SAM) 
Methionine 
Methylcobalamin 
(B12-CH3) 
Cobalamin 
(B12) 
Tetrahydrofolate 
(THF) 
5 -methylenetetrahydrofolate 
(THF-CH3) 
3Pi 
Adenosine 
triphosphate 
(ATP) 
 
Methylated 
Product 
Precursor 
H2O Adenosine 
Cobalamin (B12) 
derived from dietary 
sources 
Figure 3 Schematic showing the S-adenosylmethionine cycle, and the role of dietary cobalamin (B12). 
Adapted from (Source: BioCat, No Date:Online). 
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cardiovascular disease, in addition to global hypomethylation (Morris, 2003; 
Ganguly and Alam, 2015). 
Individuals adhering to a strict vegan diet often become deficient in B12 due to the 
predominantly animal-based nature food sources high in the vitamin. The average 
vegan diet provides less than the average daily requirement of B12, compared to 
the average omnivorous diet which provides approximately double the average 
recommended daily intake of 2.4µg  (average vegan B12 intake of 0.0 ± 0.1µg for 
females, and 0.1 ± 0.03µg for males compared to average omnivore B12 intake of 
5.0 ± 2.5µg for females, and 5.9 ± 1.5µg for males) (Larsson and Johansson, 2002; 
The National Institutes of Health Office of Dietary Supplements, 2018). 
 
  
Table 1 Selected food sources of vitamin B12 with micrograms per arbitrary serving and subsequent percentage 
of daily recommended intake. The two items suitable for those subscribing to a vegan diet are highlighted in 
yellow. Foods suitable for a lacto-ovo vegetarian diet are highlighted green. All foods listed are suitable for the 
typical omnivorous diet. (The National Institutes of Health Office of Dietary Supplements, 2018).  
 
Food 
Micrograms 
(µg) 
per serving of 
B12 
Percent 
DV* 
Clams, cooked, 3 ounces 84.1 1,402 
Liver, beef, cooked, 3 ounces 70.7 1,178 
Breakfast cereals, fortified with 100% of the DV 
for vitamin B12, 1 serving 
6.0 100 
Trout, rainbow, wild, cooked, 3 ounces 5.4 90 
Salmon, sockeye, cooked, 3 ounces 4.8 80 
Trout, rainbow, farmed, cooked, 3 ounces 3.5 58 
Tuna fish, light, canned in water, 3 ounces 2.5 42 
Cheeseburger, double patty and bun, 1 sandwich 2.1 35 
Haddock, cooked, 3 ounces 1.8 30 
Breakfast cereals, fortified with 25% of the DV for 
vitamin B12, 1 serving 
1.5 25 
Beef, top sirloin, broiled, 3 ounces 1.4 23 
Milk, low-fat, 1 cup 1.2 18 
Yogurt, fruit, low-fat, 8 ounces 1.1 18 
Cheese, Swiss, 1 ounce 0.9 15 
Beef taco, 1 soft taco 0.9 15 
Ham, cured, roasted, 3 ounces 0.6 10 
Egg, whole, hard boiled, 1 large 0.6 10 
Chicken, breast meat, roasted, 3 ounces 0.3 5 
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Of the foods listed 2 out of the 18 (both cereals fortified with varying % daily 
recommended intake of vitamin B12) are suitable for a vegan diet (yellow) in stark 
contrast to the wide range of high-B12 foods available to omnivores and vegetarians 
who consume animal products such as eggs and milk (green) (See Table 1). 
Due to this primarily animal-based nature of this vitamin, it is difficult to obtain 
sufficient B12 through plant based diet alone.  
Boxmeer et al (2013) demonstrated a significant positive correlation between B12 
seminal plasma concentration and sperm concentration in a cohort undergoing 
IVF/ICSI, in addition to an association between low seminal folate levels and DNA 
damage in sperm from fertile males.  
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1.3.2.2 Zinc 
 
Zinc is a co-factor essential to the action of DNA Methyltransferase-1 (DNMT-1) 
enzymes (responsible for the addition of methyl groups to cytosine residues in 
predominantly CpG dinucleotides by covalent bond to the 5th carbon atom in the 
pyrimidine ring). Common dietary sources of zinc include; red meats, seafood, dairy, 
fortified cereals, beans and nuts. However, many plant based sources of this mineral 
also contain phytates which inhibit zinc absorption, subsequently diminishing its’ 
bioavailability; therefore, many vegan and vegetarian diets may be lacking in this 
mineral/unable to absorb it, and may show subsequent hypomethylation (Wise, 
1995).  
In addition to its’ role in the support of DNMT-1 enzyme function, zinc has been 
implicated in maintenance of clinically ‘normal’ sperm parameters. Zhao et al (2016) 
demonstrated a positive correlation between zinc supplementation and percentage 
morphologically ‘normal’ sperm forms, motility, and increased semen volume.  
1.4 Aims & Objectives  
 
The overall aim of this research is to investigate the effects of vegan and omnivorous 
diets respectively on sperm parameters and the methylation status of sperm DNA. 
 This will be executed via the following objectives: 
1. Investigate any differences in semen parameters between omnivorous and 
vegan cohorts. 
2. Quantify total sperm DNA 5-methylcytosine levels (a marker of global 
methylation) via colorimetric Enzyme-Linked-Immunosorbent-Assay (ELISA) 
and investigate any differences in global methylation between omnivorous 
and vegan cohorts. 
3. Investigate any effect between lifestyle/biometrics and semen parameters. 
4. Investigate any interactions between semen parameters.  
The null hypothesis (H0): Dietary subscription has no significant effect on the 
methylation signature and quality of human sperm DNA. 
The alternate hypothesis (H1): Dietary subscription has a significant effect on the 
methylation signature and quality of human sperm DNA. 
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2.0 Materials and Methods 
 
Table 2 Materials used. 
 
 
 
 
 
 
 
Equipment 
-80°C Freezer Eppendorf CryoCube™F570 
Agarose Gel Electrophoresis Tank Bio-Rad SubCell® GT Cell 
Agarose Gel Imager Bio-Rad ChemiDoc™ Touch Imaging System 
Brightfield Microscope Imager Zeiss Axio Imager M1 
CASA Slides, 2 Chamber 20µm CellVision Technologies 
Cell Culture Incubator NUAIRE™ Autoflow Direct Heat CO2 Incubator 
Centrifuge Sigma 3-16KL Refrigerated Centrifuge 
Class II Laminar Flow Cabinet NUAIRE™ Biological Safety Cabinet 
Cryogenic Storage Vials 
Greiner Bio-One™ Cryo.s™ Conical Bottom 1mL 
Polypropylene Tubes with Internal Thread Cap 
Falcon Centrifuge Tubes 15 & 50ml 
Corning™Falcon™ 15ml/ 50ml Conical Centrifuge 
Tubes 
Flat Cap PCR Tubes 0.2ml STARLAB 
Light Microscope Leica DM500 Light Microscope 
Microcentrifuge Labnet Prism Air-Cooled Microcentrifuge 
Neubauer Improved Haemocytometer 
Rhodium Coated 
Hawksley Medical and Laboratory Equipment 
Pasteur Pipettes 
SLS Select PIP4204 Polyethylene Pasteur Pipette, 
Individually Wrapped, Sterile, 1 mL 
pH Electrode Mettler-Toledo InLab® Micro 
pH Meter 
Mettler Toledo™ FE20 FiveEasy™ Benchtop pH 
Meter 
Pipette Tips STARLAB TipOne® Pipette Tips 
Pipettes Gilson 
Plate Reader  Synergy HT plate reader, BioTek® Instruments 
Power Supply for Gel Electrophoresis Bio-Rad PowerPac™ Basic Power Supply 
Pyrosequencer Qiagen PyroMark Q24 Pyrosequencer 
Sample Collection Pots Sterilin UK 
Shaking Incubator Labnet AccuTherm™ Microtube Shaking Incubator 
Slides ThermoScientific™ SuperFrost™ Plus 
Spectrophotometer ThermoScientific NanoDropOne 
SAMi Pro-Creative Diagnostics 
Thermal Cycler Agilent Technologies SureCycler 8800 
Vortexer SLS Lab Basics Vortexer 
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2.1 Participant Recruitment and Sample Procurement 
 
Semen samples were obtained from consenting donors aged 22-40, covered by 
faculty ethical approval at Manchester Metropolitan University (EthOS Reference 
Number: 0482; SE1617127)(Ethical approval in Appendix 7.2). Donors were 
verbally informed of the study details and given a participant information sheet with 
details of the study (Appendix 7.3). Participants consented (Appendix 7.4) and 
completed a medical screening questionnaire upon their first visit (Appendix 7.5). 
All participants were self-reported non-smokers per the food frequency 
questionnaire (FFQ) (Appendix 7.6), and were selected based upon exhibition of 
normozoospermic parameters including; total sperm count, concentration, 
progressive motility and vitality according to World Health Organisation (WHO) 
reference ranges (WHO, 2010). 
Consumables, Chemicals and Reagents 
25bp Ladder Bioline Hyperladder™ 25bp 
5-methylcytosine Detection Kit 
Epigentek MethylFlash™ Methylated DNA 
Quantification Kit (Colorimetric) 
Agarose Bio-Rad Certified™ Molecular Biology Agarose 
Bisulphite Conversion Kit Qiagen EpiTect Bisulphite Conversion Kit 
Boric Acid Fisher-Scientific 
Chloroform VWR Chemicals 
Eosin-Y Colour Sigma-Aldrich 
Ethanol Fisher Scientific 
Ethylenediaminetetraacetic acid Fisher Scientific 
Isoamyl Alcohol Sigma-Aldrich 
Isopropanol Fisher Scientific 
Nigrosin Sigma-Aldrich 
PCR Kit Qiagen Pyromark PCR Kit 
Phenol Sigma-Aldrich 
Predesigned Primers Qiagen CpG Assay 
Pyrosequencing Kit Qiagen PyroMark Gold Q24 Reagents 
Sodium Chloride Sigma-Aldrich 
Sodium Dodecyl Sulphate Sigma-Aldrich 
Tris(hydroxymethyl)aminomethane 
hydrochloride 
Sigma-Aldrich 
Colloidal Suspension for Density 
Gradient  
Nidacon PureSperm 100 
Phosphate-Buffered-Saline Invitrogen™ by ThermoFisher Scientific 
Water for Molecular Biology Acros Organics 
Software 
CASA Data Capture  SAMi, Procreative Diagnostics 
Plate Reader Data Capture  Gen5™ software version 2.05.5 
Data Processing Microsoft® Excel for Mac Version 16.18 
Statistical Analysis GraphPad Prism® 7.0e for Mac OS X 
Table 1. Materials used, with manufacturer’s details.  
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Each participant completed the food frequency questionnaire on the day of donation, 
detailing the 3 months’ prior diet and biometrics (age, height, weight).  
Food consumption frequency was measured on a 7- point descriptive scale. 0-
Never, 1-Less than once a month, 2- 1-2 times a month, 3- Once a week, 4- 2-3 
times a week, 5- 4-6 times a week, 6 – Every day.   
Participants were assigned to one of two groups according to their self-reported diet 
(vegan, omnivorous) (5 participants per dietary group). All participants had followed 
their current diet for a minimum of 3 months (1 cycle of spermatogenesis 70 days) 
(Kretser, 2000) prior to donation. Participants were pseudonymised by the following 
system: VGANXX/ OMNIXX for example; VGAN01, OMNI01, VGAN02, OMNI02 
etc. 
All semen samples were produced on site at Manchester Metropolitan in a 
designated, private room for sperm donation. Participants were verbally provided 
with information on how to produce the sample and given a sample collection pot 
(Sterilin, UK).  
All neat semen samples underwent standard semen analysis according to the WHO 
5th edition manual for the examination and processing of human semen before 
processing. Semen was allowed for liquefication at 37°C for 30 minutes in a direct 
heat 5% CO2 incubator. The total volume of semen was measured and recorded. 
Semen pH was measured immediately after the 30 minute liquefaction period using 
a pH meter & probe (Mettler – Toledo). 
2.2 Sperm Motility and Concentration 
 
Sperm motility and concentration was assessed using Computer Assisted Sperm 
Analyser (CASA – Sami®, Procreative). Briefly, 5 μl of semen was applied to a cell 
counting slide (Vitrolife, UK) and analysed by CASA. Using a heated stage (37.5°C) 
concentration, speed, and percentage motility (A= progressively motile B= Non-
linear motility C= progressively immotile D=Immotile) were calculated by software 
(SAMi®, Procreative Diagnostics) and noted in addition to the presence of debris, 
round cells and agglutination. Samples were snap frozen in liquid nitrogen and 
stored at -80°C until required.  
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2.3 Vitality Assay 
 
Eosin-nigrosin stain was prepared per the WHO laboratory manual for the 
examination and processing of human semen (5th Edition, 2010) by dissolving 
0.67g of eosin Y and 0.9g of NaCl in 100ml purified water with a magnetic stirrer. 
Nigrosin (Sigma-Aldrich) (10g) was added to the solution, which was heated to 60°C 
then left to cool to room temperature, and filtered to remove impurities. The resulting 
suspension was stored at room temperature in a sealed dark glass bottle.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Vitality slides were produced in duplicate using eosin-nigrosin dye-exclusion assay. 
A total of 20µl semen and 20µl eosin-nigrosin stain (10µl/10µl per slide) was mixed 
using a pipette to ensure homogeneity in 1.5ml Eppendorfs, and the stain produced 
by the feathering technique recommended by WHO (WHO, 2010) (Figure 4). Slides 
were examined using brightfield optics at x1000 magnification with oil immersion. A 
live-dead percentage score was obtained from 200 cells per slide (each slide 
counted in duplicate) obtaining an overall average live-dead score per participant. 
Dead sperm stain dark pink due to the influx of dye, live sperm remain white due to 
their intact membrane (Figure 5).  
The semen 
solution is drawn 
across the edge 
of the second 
slide on contact. 
1
. 
2
. 
3
. 
Application point 
(20µl semen & eosin-
nigrosin solution). 
4
5
° 
Gentle pressure 
is applied to 
create the smear 
by dragging the 
second slide over 
~1 second. 
Figure 4 Schematic demonstration of the feathering technique used for vitality assay. (1) Application. (2) Direction of drag 
used to create smear. (3) Completed vitality slide left to air dry. 
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2.4 Sperm Preparation 
 
2.4.1 Separation of Sperm from Seminal Plasma 
 
Sperm were isolated from the seminal plasma via centrifugation at 300g for 10 
minutes. The supernatant will be divided into 0.5ml Eppendorfs  and snap-frozen in 
liquid nitrogen prior to transfer to a -80°C freezer pending further analysis. The 
resulting sperm pellet will be transferred to a cryogenic vial (Greiner BioOne™) 
snap-frozen and stored at 80°C. 
2.4.2 Separation of Germ and Somatic cells 
 
In order to ensure sperm samples were free of somatic (round) cell contamination – 
methods of somatic cell eradication was explored. This was important for 
downstream sperm DNA methylation analysis.  
‘Round cells’ is an umbrella term referring to the presence of somatic cells such as 
epithelial and white blood cells in the semen, in addition to immature germ cells 
(spermatids), all of which are commonly found in the clinically ‘normal’ ejaculate. 
The most predominant round cell type in the ejaculate is the leukocyte. The World 
Figure 5 Eosin-Nigrosin stain showing 2 dead sperm with permeabilised membranes (stained dark) and one 
live sperm with intact membrane (centre) (white, no stain). Taken using Zeiss Axio imager M1 at 63x/1.4 
objective with oil immersion (Zeiss).  
 
Dead sperm 
Live sperm 
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Health Organisation (WHO) defines leukocytospermia as 1x106 /ml leukocytes in the 
ejaculate (WHO, 2010). 
Both Density Gradient Centrifugation (DGC) and somatic cell lysis detergents were 
assessed. 
2.4.3 Sperm Isolation Techniques 
 
In recent years, there has been a drive for researchers to develop and diversify 
sperm isolation techniques in order to accommodate and reflect the vast range of 
infertility aetiologies presenting in the clinic. A patient presenting with 
oligozoospermia or cryptozoospermia would not be a suitable candidate for 
procedures based upon migration such as swim-up or migration-sedimentation due 
to the low yields obtained through these methods. In this case, separation 
techniques such as density gradient centrifugation or glass-wool filtration would be 
a more beneficial method of isolation, delivering a higher yield.  
Behind this drive is the shift from the antiquated belief that, infertility is a 
predominantly female issue. Male factors are the exclusive cause of infertility in 20-
30% of cases, furthermore; male factors contribute alongside female factors to 50% 
of cases (Agarwal et al, 2015).  
As participants were not recruited from an IVF clinic and were selected based upon 
samples meeting the WHO semen characteristics reference range, it is known that 
they are normozoospermic samples. 
Density gradient centrifugation and somatic cell lysis methods were assessed as 
these are suitable for normozoospermic samples, provide high yields, and are 
among the most popular techniques documented in recent literature.  
2.5.3.1 Initial Sample Preparation 
 
Following liquefaction, the fresh sample was centrifuged at 300g for 10 minutes in 
order to artificially concentrate the sperm & round cell populations (all centrifugation 
steps are performed at ambient temperature unless stated otherwise). The pellet 
was then re-suspended in 2ml phosphate-buffered-saline (PBS) pre-warmed at 
37°C. 
Baseline sperm count and round cell count was assessed via a haemocytometer 
count according to WHO procedures (WHO, 2010). 
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The remainder of the sample was divided equally into 2x clean centrifuge tubes 
(Corning™Falcon™), pending exposure to the 2 sperm isolation techniques. 
Results of these techniques are included in the appendix (Appendix 7.1). 
2.5.3.2 Density Gradient Centrifugation  
 
A discontinuous, two-step gradient was used (Figure 6). Silane-coated silica 
particles in differing concentrations suspended in PBS provide the density of both 
media (PureSperm 100 (Nidacon) was diluted appropriately to obtain the 40% and 
80% suspensions used). The principal of density gradient centrifugation (DGC) is 
that progressively motile sperm are capable of crossing the interphase between the 
two media faster, travelling through the denser media (lower phase, 80%) in the 
direction of the centrifugal force. Progressively immotile, immotile and decapitated 
sperm, round cells and debris are maintained within the lighter (upper phase, 40%) 
of the gradient (Figure 7).  
This upper phase was discarded, leaving the lower phase containing a pure 
population of progressively motile sperm. 
 
 
 
 
 
 
 
 
 
  
Figure 6 Schematic showing the principle of density gradient centrifugation. A two-step discontinuous 
gradient was used. 
 
2ml Lower Phase 
80% 
SupraSperm  
2ml Upper 
Phase 40% 
SupraSperm 
Sperm pellet 
Interphase between 
the two gradients 
Motile, viable 
sperm  
Round cells, 
Immotile 
sperm, debris   
Seminal 
plasma  1ml Re-suspended 
Sperm 
20-minute centrifugation at 300g  
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Density gradient centrifugation was performed on one remaining aliquot of washed 
sperm, using the PureSperm system (Nidacon). PureSperm 40% and PureSperm 
80% were pre-warmed at 37°C in a water bath prior to gradient preparation. In a 
15ml Falcon tube, 2ml PureSperm 40% was underlaid with 2ml 80% PureSperm. 
Re-suspended sperm (1ml) was pipetted to ensure homogeneity before being 
carefully dispensed on top of the prepared gradient using a Pasteur pipette; being 
sure not to disrupt the layers. At this point, clear definition between the layers should 
be visible (Figure 6). After centrifugation at 300g for 20 minutes, the supernatant 
was discarded and the pellet transferred to a clean 15ml Falcon tube, re-suspended 
in 2ml pre-warmed PBS and centrifuged at 300g for 10 minutes. This washing step 
was repeated and the resulting pellet re-suspended in 2ml pre-warmed PBS. 
To ensure sperm samples were free from round cell contamination prior to DNA 
extraction – both density gradient and somatic cell lysis (SCL) was carried out (see 
Appendix 7.1 for SCL method).  
Density gradient centrifugation was found to be more effective in eliminating 
round/somatic cells.  
 
2.5.3.3 Application of DGC to Experimental Samples – Optimisation 
 
It was observed that no cellular components of any kind formed a pellet, nor did 
they migrate past the interphase of the traditional two-step discontinuous gradient. 
Lower phase - motile, viable sperm  
Upper phase - round cells, immotile sperm, 
debris 
Interphase between the two 
gradients 
Figure 7 Schematic demonstrating the cellular components and separation post- density 
gradient separation.   
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All sperm were retained at the interphase, within the upper 40% suspension. This 
was presumably due to the sperm’s immotility post-thaw. 
Therefore, the method for post-thaw density gradient centrifugation was modified 
(Figure 8) to a simple one-step gradient using only 40% PureSperm, overlaid with 
the thawed pellet (reconstituted in an equivolume of PBS). 
 
 
 
 
 
 
 
 
 
Following a 20 minute centrifugation at 300g, the supernatant containing round cells 
and debris (Figure 8) was aspirated and discarded in addition to the media, leaving 
the sperm pellet. The pellet was then washed in 2ml PBS and centrifuged at 500g 
for 5 minutes. Aliquots (12.5µl) were taken from each sample at this point, and 
added to 50µl PFA fixative, and a haemocytometer count taken to establish whether 
each sample contained the minimum cellular threshold for a suitable DNA yield for 
later analysis. Total sperm count at initial semen processing and total sperm count 
post-density gradient centrifugation are displayed in Table 3. 
The supernatant was discarded and the pellet transferred to a cryogenic vial 
(Greiner BioOne™) prior to flash-freezing in liquid nitrogen. The pellets were then 
returned to a -80C freezer pending further processing.  
 
 
 
 
 
Figure 8 Density gradient centrifugation modified to a one step continuous gradient consisting of 40% 
PureSperm media.  
 
2ml Single-step 
continuous phase 
40% SupraSperm 
Post-thaw sperm 
reconstituted in an 
equivolume of PBS 
2ml Single-step 
continuous phase 
40% SupraSperm 
Round 
cells,  
cell debris   
Sperm pellet 
20-minute centrifugation at 300g  
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Table 3  Total sperm count at initial semen processing (x106) and post-density gradient centrifugation, analysed 
by computer assisted sperm analysis for omnivorous and vegan diets. 
 
 
 
2.5 DNA Extraction & Purification 
 
Phenol-chloroform method of DNA extraction was optimised for maximum recovery 
of sperm DNA. Optimisation was necessary to obtain the correct yield of DNA 
consistently per sample, in order to satisfy minimum working concentrations of DNA 
necessary for the subsequent global methylation assay (a minimum working 
concentration of 50ng genomic DNA per sample). 
Semen samples were also procured for this purpose per section 2.1. 
Phenol-Chloroform method of DNA extraction was selected due to its high yield and 
popularity in literature. 
Sperm pellets were removed from -80C storage and allowed to thaw at ambient 
temperature prior to transfer to sterile 1.5ml Eppendorfs. 500µl lysis buffer 
containing 10% SDS (sodium dodecyl sulphate), 0.5M EDTA 
(Ethylenediaminetetraacetic acid), 1M Tris(Tris(hydroxymethyl)aminomethane 
hydrochloride) (pH 8) and 5M NaCl (sodium chloride was added, in addition to 25µl 
proteinase K. Eppendorfs were vortexed and incubated at 50C for 20 minutes with 
agitation.  
Following incubation, 500µl 25:24:1 phenol:chloroform:isoamyl alcohol was added, 
and the samples vortexed prior to centrifugation at 12,000g, 4C for 15 minutes. 
Sample 
Total Sample Sperm Count at 
Initial Semen Processing (x106) 
Total Sperm Count Post-Density 
Gradient Centrifugation (x106) 
VGAN01 252.48 76.75 
VGAN02 223.42 13.6 
VGAN03 71.65 28.5 
VGAN09 397.34 85 
VGAN10 419.98 81.75 
OMNI02 562.41 30 
OMNI05 231.93 31 
OMNI08 125.19 14.6 
OMNI09 122.48 30 
OMNI11 564.68 65.5 
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Being sure not to disrupt the bottom layer, the supernatant was transferred to new 
Eppendorfs, and an equivolume of chloroform added, vortexed and centrifuged at 
12,000g, 4C for 5 minutes. Supernatant was transferred to new Eppendorf, and an 
equivolume of cold isopropanol added prior to inversion by hand and centrifugation 
at 12,000g, 4C for 10 minutes. Following centrifugation, the supernatant was 
discarded, and 500µl 70% cold ethanol was added, the tubes inverted by hand, and 
centrifuged at 12,000g, 4C for 5 minutes. The supernatant was discarded and the 
step repeated by addition of 500µl 70% cold ethanol, inversion and centrifugation at 
12,000g, 4C for 5 minutes. The supernatant was discarded and any remaining 
ethanol removed using a p10 pipette, with all samples pulse-spun in a 
microcentrifuge (Labnet) to remove any residual ethanol. Tubes were allowed to air 
dry for 1 minute under the fume hood and eluted with 100µl TE buffer prior to DNA 
quantification using a nanodrop spectrophotometer. (See Figure 9 for a schematic 
overview of the 5 main steps in phenol-chloroform extraction). 
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Figure 9 Schematic of the main 5 steps of phenol chloroform extraction and ethanol precipitation. 
 
1. 
Thawed sperm pellet 
resuspended in 500µl lysis 
buffer and 25µl proteinase K. 
20 minute 
incubation at 56C 
with agitation. 
2. 
Lysed cellular 
debris. 
Addition of 25:24:1 
phenol:chloroform:isoamyl 
alcohol prior to 
centrifugation at 4C, 
12,000g for 15 minutes. 
3. 
Organic phase 
containing cell 
debris. 
Interphase.  
Aqueous phase containing DNA. 
Following 
centrifugation 
steps and ethanol 
precipitation. 
4. 
 
DNA pellet. 
5. 
 
DNA re-suspended in 
sterile, filtered, TE 
buffer. 
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DNA was quantified using NanoDropOne (ThermoFisher). The nanodrop was 
blanked using 1µl TE buffer (10mM Tris-HCl 1mM EDTA Na2, pH 8) prior to testing 
each sample using 1µl volumes. Quantity (ng/µl) and purity (A260/A280, 
A260/A280) of DNA recovered per sperm sample is displayed in Table 4 below. 
Samples were then stored at -20C until further use.  
 
Table 4 DNA quantities (ng/µl) and purity ratios at A260/A280 and A260/A230 per sample using 
NanoDropOne spectrophotometer (Thermoscientific). 
 
 
 
 
 
 
 
 
 
 
2.6 Quantification of Global Methylation Levels 
 
Epigentek MethylFlash Methylated DNA 5-mC Quantification Kit (Colorimetric) 
(Epigentek Group Inc) was used to quantify levels of 5-methylcytosine% and thereby 
quantify global methylation per sample (Vryer and Saffery, 2017).  
Recommended genomic DNA input was 50ng-200ng, 50ng was used due to the 
limitations of sample size. This allowed the experiment to be run in duplicate. 
Experimental setup is shown in Figure 10. 
2.6.1 DNA Binding 
 
Binding solution (80µl) was added to each of the 24 wells using a multi-channel 
pipette. Negative control (1µl), positive control (1µl) and varying volumes all 
constituting 50ng genomic DNA from each sample, equilibrated to 8µl with nuclease 
free water were added in duplicate to corresponding wells shown in Figure 10. The 
Sample DNA (ng/µl) Purity A260/A280 Purity A260/A230 
VGAN01 28.8 1.85 2.16 
VGAN02 3.6 1.76 1.79 
VGAN03 10.0 1.61 1.61 
VGAN09 53.2 1.77 1.03 
VGAN10 7.1 1.53 1.75 
OMNI02 36.3 1.83 2.26 
OMNI05 11.2 1.89 1.42 
OMNI08 13.2 1.66 1.08 
OMNI09 10.5 1.74 1.37 
OMNI11 19.0 1.88 1.49 
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plate was then covered using plate seal, and incubated at 37°C for 90 minutes to 
facilitate DNA binding. 
2.6.2 Methylated DNA Capture  
 
The solution was removed from all wells, which were then washed 3 times with 150µl 
wash buffer, which was then discarded from the wells. Diluted capture antibody 
(50µl) was then added to each well, and the plate covered and incubated at room 
temperature for 60 minutes. Capture antibody was then discarded, and all wells 
washed 3 times using 150µl wash buffer. Diluted detection antibody (50µl) was 
added to each well, and the plate covered and incubated at room temperature for 
30 minutes. Detection antibody was then discarded and each well washed 4 times 
using 150µl wash buffer. Enhancer solution (50µl) was then added to each well, and 
the plate covered and incubated at room temperature for 30 minutes. Enhancer 
solution was then discarded and each well washed 5 times using 150µl wash buffer. 
2.6.3 Signal Detection 
 
Developer solution (100µl) was added to each well, and the plate incubated in the 
absence of light at room temperature for 12 minutes. Stop solution (100µl) was 
added to each well to stop the enzyme reaction. Absorbance was measured at 
450nm after 2 minutes as suggested by the manufacturer’s guidelines. 
Synergy HT plate reader was used (BioTek® Instruments) was used to read the 
strip-well plate, and Gen5™ software version 2.05.5 used for data capture.  
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Figure 10 Schematic Representation of the strip-well plate used, with duplicate 
negative & positive controls, and samples.  
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2.6.4 Relative Quantification of 5-methylcytosine 
 
Relative quantification using single point control to determine the relative 
methylation status of the omnivorous and vegan cohorts was carried out. The 
equation below, provided by the manufacturer (Epigentek) was used to quantify the 
percentage of 5-methylcytosine% in the total sperm DNA of each sample: 
 
5 − 𝑀𝑐% =
(𝑆𝑎𝑚𝑝𝑙𝑒 𝑂𝐷450 − 𝑁𝑒𝑔𝑎𝑡𝑖𝑣𝑒 𝐶𝑜𝑛𝑡𝑟𝑜𝑙 𝑂𝐷450) ÷ 𝑆 
(𝑃𝑜𝑠𝑖𝑡𝑖𝑣𝑒 𝐶𝑜𝑛𝑡𝑟𝑜𝑙 𝑂𝐷450 − 𝑁𝑒𝑔𝑎𝑡𝑖𝑣𝑒 𝐶𝑜𝑛𝑡𝑟𝑜𝑙 𝑂𝐷450) 𝑥 2 ÷ 𝑃
 𝑥 100% 
 
Where: 
 S is the amount of sample DNA input in ng  
 P is the amount of positive control input in ng  
 
2.7 Data Collection & Statistical Analysis 
 
Microsoft® Excel for Mac Version 16.18 was used for all data collection and 
processing. GraphPad Prism® 7.0e for Mac OS X was used for all statistical 
analysis. The Shapiro-Wilk test for normality was used to identify Gaussian 
distribution of all data sets and identify subsequent appropriate tests. Potential 
confounding factors including age, BMI and alcohol intake were all tested for 
normality. Age was the only factor that was not normally distributed and was 
therefore tested for any correlations with all other datasets. No associations were 
found, therefore there was no need to control for age as a confounding factor.  
Unpaired t-tests were used to calculate any significance in sperm parameters 
between the two dietary groups, except pH data which was not normally distributed; 
where a Mann-Whitney test was used. 
Associations between various parameters (with datasets from both dietary groups 
combined as a whole) were calculated.  
Correlation for nonparametric data (global methylation) was calculated via 
Spearman correlation and linear regression analyses, and for parametric data 
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correlation was calculated via Pearson correlation coefficient and linear regression 
analyses. 
 
GraphPad software was also used to produce graphs; each plotted as mean± 
standard error of the mean (SEM). 
Self-reported biometrics were used to calculate body mass index scores (BMI) via 
the equation: 
 
𝐵𝑜𝑑𝑦 𝑀𝑎𝑠𝑠 𝐼𝑛𝑑𝑒𝑥 =
𝑊𝑒𝑖𝑔ℎ𝑡 (𝐾𝑖𝑙𝑜𝑔𝑟𝑎𝑚𝑠)
𝐻𝑒𝑖𝑔ℎ𝑡(𝑀𝑒𝑡𝑟𝑒𝑠)2
  
 
Self-reported exercise frequency and level of strenuousness was used to calculate 
Godin Leisure Index Scores (LSI) via the equation: 
 
𝑊𝑒𝑒𝑘𝑙𝑦 𝐿𝑒𝑖𝑠𝑢𝑟𝑒 𝐴𝑐𝑡𝑖𝑣𝑖𝑡𝑦 𝑆𝑐𝑜𝑟𝑒 = (9𝑥𝑆𝑡𝑟𝑒𝑛𝑢𝑜𝑢𝑠) + (5𝑥𝑀𝑜𝑑𝑒𝑟𝑎𝑡𝑒) + (3𝑥𝐿𝑖𝑔ℎ𝑡) 
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3.0 Results  
 
3.1 Part 1 – Impacts of Omnivorous and Vegan diets  
 
3.1.1 Sperm Parameters 
 
Sperm parameters were measured for each dietary cohort (total sperm count, 
motility, concentration, vitality and pH). Red dotted lines signify WHO (2010) lower 
reference ranges for each of the sperm parameters used in the selection criteria for 
normozoospermic samples (Section 2.1). The data were analysed for normality 
using Shapiro-Wilk test, normally distributed data were analysed via parametric 
tests (t-test) and non-normally distributed data were analysed via non-parametric 
tests (Mann-Whitney test). All parameters were normally distributed except for pH 
values.  
There were no statistically significant difference between the total sperm count, 
motility, concentration, vitality or pH between vegan diets and omnivorous diets 
(Figure 11).  
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Figure 11 Sperm parameters for omnivorous(OMNI) and vegan (VGAN) diets. WHO lower reference ranges 
for the respective parameter represented as red dotted lines on each graph (WHO, 2010). A– Total sperm count 
for omnivorous and vegan diets calculated using concentration (x106/ml) and ejaculate volume (ml) 
(p=0.6954)(unpaired t-test). B – Sperm percentage progressive motility (fast progressive + slow 
progressive(A+B)) analysed via computer assisted sperm analysis for omnivorous and vegan diets 
(p=0.9129)(unpaired t-test). C– sperm concentration (x106/ml) analysed via computer assisted sperm 
analysis(p=0.6668)(unpaired t-test). D- sperm vitality (%live) Duplicate eosin-nigrosin dye exclusion assay 
quantified via duplicate examination of slides using 1000x magnification with oil immersion (p=0.8606)(unpaired 
t-test). E- Seminal pH measured by pH probe (p>0.9999)(Mann-Whitney test). Error bars represent mean ± 
standard error of the mean (SEM). No significant difference in any sperm parameters was observed between 
the dietary cohorts p>0.05, n=5 per dietary cohort. P-values are reported at 95% confidence intervals. 
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3.1.2 Global methylation 
 
The primary aim of this research was to establish any significant differences in the 
global methylation of total sperm DNA for those subscribing to a vegan or 
omnivorous diet. This was measured by 5-methylcytosine% (an indicator for global 
methylation) percentage in total sperm DNA (Vryer and Saffery, 2017).  
No significant difference in percentage 5-methylcytosine% was found between the 
vegan and omnivorous diet cohorts (Figure 12), however the range of percentage 
total DNA 5-methylcytosine% within the vegan cohort (4.06, n=5) was larger than 
that of the omnivorous cohort (0.94, n=5). 
 
Figure 12 Global methylation (5-methylcytosine% in total DNA) between the vegan and omnivorous diets 
(p=0.1954)(unpaired t-test) (n=5 per dietary group). Error bars represent mean ± SEM. Measured using 
MethylFlash Global DNA Methylation (5-mC) ELISA Easy Kit (Colorimetric) (Epigentek). 
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3.1.3 Evaluation of potential confounding factors from biometrics and 
lifestyle 
 
The possible confounding factors were analysed via unpaired t-tests to identify if 
there was a difference between any potential confounding factors (age, BMI and 
alcohol consumption) for the vegan and omnivorous dietary cohorts. No significant 
differences were found (Table 5).  
The leisure score index (section 2.7) is an arbitrary measurement of weekly exercise 
used to identify insufficiently active (≤23) and active (>24) lifestyles (Godin and 
Shephard,1985). The LSI classification could also be a potential confounding factor 
however; there was no significant difference between the score for vegan and 
omnivorous dietary cohorts (Table 6).  
As no differences were found, no confounding factors needed to be accounted for 
in statistical analyses. 
 
Table 5 Biometrics & Lifestyle factors between dietary cohorts. *a Median (IQR) *bMean ±SEM. P-values 
calculated via unpaired t-tests. 
Biometrics & Lifestyle factors   p-values  
Age
a  
(years) VGAN 
OMNI 
33 (26 – 34), n=5 
23 (22.5 – 32.5), n=5 
0.5317 ns 
BMI
b 
(kg/m2) VGAN 
OMNI 
23.38 ± 0.9265, n=5 
24.18 ± 1.345, n=5 
0.6374 ns 
Alcohol consumption
b  
(units/week) VGAN 
OMNI 
8.8 ± 4.841, n=5 
5.6 ± 2.315, n=5 
0.5675 ns 
     
Table 6 LSI partition between dietary cohorts for insufficiently active (≤23) and active participants (>24). 
Calculated via Fisher’s contingency test (p>0.999). 
 
 
 
 
 
  
Leisure Score Index ≤23 >24 Significant 
OMNI 0 5 
ns 
VGAN 1 4 
 35 
3.2 Part 2 – Investigation of Global Methylation and Sperm Parameters 
and Lifestyle and Biometric Factors 
 
Due to the lack of significance between the vegan and omnivorous dietary cohorts 
(Figure 11;Figure 12;Table 5;Table 6) the dietary datasets were combined. This was 
statistically valid as neither of the dietary cohorts demonstrated any significance in 
any areas, and therefore the combined datasets are representative of the 
population. This allowed further correlational analysis into the effects of lifestyle and 
biometrics on sperm parameters and any interactions between sperm parameters, 
irrespective of dietary subscription. 
 
3.2.1 Sperm parameters 
 
Table 7 demonstrates mean sperm parameters of the combined cohort (n=10). 
Table 7 Sperm parameters (n=10) displayed as mean±SEM. 
Sperm parameters Mean ±SEM 
Total Sperm Count (x106) a  297.2 ± 56.73 
Sperm Concentration (x106/ml) a     106 ± 23.29 
Progressive Motility (% A+B) a   69.12 ± 4.34 
Vitality (% live) a   87.54 ± 1.28 
 
Subsequently, any relationship between sperm parameters and global methylation 
of total sperm DNA of the combined cohort was investigated via correlational 
analysis (Pearson’s Correlation). No significant correlation was identified between 
the sperm parameters and global methylation of total sperm DNA (Table 8).  
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Table 8 Correlation between sperm parameters and global methylation using Pearson’s correlation (displayed 
as r=coefficient value(p-value) (ns=no significance). 
Sperm parameters r (p-values) Significance 
Total Sperm Count (x106) 
0.1945 
(0.5889) 
ns 
Sperm Concentration (x106/ml) 
0.3587 
(0.3063) 
ns 
Progressive Motility (% A+B)  
0.1945 
(0.5889) 
ns 
Vitality (% live) 
-0.1824 
(0.6136) 
ns 
 
  
 37 
3.2.2 Lifestyle and biometrics  
 
Table 9 demonstrates biometrics & lifestyle factors of the combined cohort (n=10). 
(Parametric data shown as mean ± SEM, nonparametric data shown as median 
(interquartile range(IQR)). 
 
Table 9 Biometrics & Lifestyle factors *amean ±SEM *bmedian(Interquartile Range). 
Biometrics & Lifestyle 
factors 
Mean±SEM/Median(IQR) 
  Age (years)a  28.6 ± 2.088 
  Body Mass Index (kg/m2)a 23.78 ± 0.7814 
  Alcohol (units/week)b 5 (0-12) 
  Leisure Score Indexb 47.5 (34.75-75.25) 
 
A relationship between biometrics & lifestyle factors and global methylation of total 
sperm DNA of the combined cohort was investigated via correlation analysis 
(Pearson’s Correlation for age and BMI (parametric), Spearman’s Correlation for 
alcohol and LSI(nonparametric)). No significant correlation was identified between 
the biometrics & lifestyle factors and global methylation of total sperm DNA (Table 
10). 
 
Table 10 Correlation of Biometrics & Lifestyle factors *c Pearsons Correlation *d Spearmans Correlation (ns=no 
significance). 
Biometrics & Lifestyle 
factors 
r (p-values) Significance 
Age (years)c 0 (>0.9999) ns 
Body Mass Index (kg/m2)c -0.0581 (0.8727) ns 
Alcohol (units/week)d 0.0432 (0.9074) ns 
Leisure Score Indexd 0.2067 (0.5651) ns 
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3.3 Part 3 – Investigation of the Impact of Biometrics & Lifestyle 
Factors on Sperm Parameters and Their Interaction 
 
Any relationship between biometrics & lifestyle factors and sperm parameters of the 
combined cohort were investigated via correlation analysis.  
3.3.1 Sperm parameters and lifestyle  
 
To investigate any relationship between biometrics & lifestyle factors and sperm 
parameters of the combined cohort, correlation analysis was performed using 
Pearson’s correlation for age and BMI (parametric) and Spearman’s correlation for 
alcohol and LSI (non-parametric). No significant correlation was found (Table 11). 
 
Table 11 Associations between biometrics & lifestyle factors and sperm parameters. Displayed as 
r=correlation coefficient(p-value) *aPearsons correlation *b Spearmans Correlation. 
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-0.3294  
(0.3527) 
-0.2828  
(0.4286) 
-0.1108  
(0.7615) 
0.5152  
(0.1334) 
Sperm Concentration(x10
6
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 -0.5589  
(0.0930) 
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0.0667 
 (0.8651) 
Vitality(% live)
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(0.8970) 
0.297  
(0.4069) 
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3.3.2 Dependence of sperm parameters 
 
Any relationship between the sperm parameters in the combined cohort was 
investigated via Pearson’s correlation analysis. 
Progressive motility and sperm concentration in the combined cohort were found to 
be significantly positively correlated (r=0.7766, p=0.0082). The progressive motility 
and vitality in the combined cohort were also found to be significantly positively 
correlated (r=0.6535, p=0.0404) (Table 12). 
 
Table 12 Interaction between semen parameters. *aPearsons Correlation data presented as r=correlation 
coefficient(p-value). 
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6
/ml)
 a   
0.7766 
(0.0082)** 
0.6038 
(0.0645) 
Progressive Motility (% A+B)
 a    0.6535 (0.0404)* 
 
 
 
Figure 13 A - Pearson correlation of progressive motility (A+B)% vs vitality (%live) r=0.6535 p=0.0404* in the 
total dataset. B - Pearson correlation of concentration (x106/ml) vs progressive motility (A+B)% r=0.7766 
p=0.0082** in the combined cohort.  
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3.3.3 Independence of Biometrics & Lifestyle Factors 
  
Any relationship between the biometrics & lifestyle factors was investigated via 
Pearson’s correlation for age and BMI (parametric) and Spearman’s correlation 
analysis for alcohol and LSI (nonparametric). There was no statistically significant 
correlation found between biometrics & lifestyle factors in the combined cohort  
(Table 13). 
 
Table 13 Interaction between biometrics and lifestyle factors. Displayed as r=correlation coefficient (p-value) 
*aPearsons correlation *bSpearmans Correlation. 
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  Age (years)a
  -0.3689 
(0.2941) 
0.3684 
(0.2899) 
-0.3171 
(0.3693) 
  Body Mass Index (kg/m
2
)a
   -0.1579 
(0.6593) 
0.3049 
(0.3887) 
  Alcohol (units/week)b
    -0.2585 
(0.4674) 
  Leisure Score Indexb
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4.0 Discussion 
 
Lifestyle and environment are important influences in human health. There are many 
aspects of lifestyle that are known to affect reproductive health such as alcohol 
intake, recreational and pharmaceutical drugs, smoking cigarettes and a BMI 
outside of the healthy range. Poor dietary choices in combination with sedentary 
lifestyle likely lead to obesity, which in turn, is implicated as a risk factor in diseases 
such as stroke, diabetes, cancer (Dixon, 2010) and well documented negative 
effects on reproduction and fertility outcomes (Hammoud et al, 2008a; Broughton 
and Moley, 2017). 
The epigenome responds to its environment. Lifestyle factors such as diet and 
obesity could have an impact in inducing aberrant DNA methylation, which has been 
associated with male infertility and poor semen parameters.  
Global DNA methylation has previously been shown to be a poor marker for 
infertility, although global DNA methylation has been shown to decline with age 
(Nevin and Carroll, 2015). However, decreased global methylation has been shown 
to be associated with male infertility and poor sperm quality (Benchaib et al, 2003). 
Global DNA methylation assays are a cost-effective method to analyse DNA 
methylation, particularly in cases where the candidate genes are unknown. Global 
DNA methylation analysis is therefore a good method for discovering unknown 
epigenetic changes. 
As decreased global methylation could be associated with infertility, this research 
investigated if diet, lifestyle or biometrics had any correlation with global methylation. 
As a pilot study, the aim of this study was to investigate any potential relationship 
between dietary choice, semen parameters and sperm DNA methylation status. 
Global methylation levels were estimated via percentage of total DNA 5-
Methylcytosine present using an ELISA based assay (Epigentek).  
All participants self-reported  as non-smokers and any other potentially confounding 
factors were investigated to ensure that they were accounted for in the statistical 
analysis (Table 5; Table 6). 
 
4.1 Part 1 – Impacts of Omnivorous and Vegan diets 
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4.1.1 Sperm parameters 
 
Diet and sperm parameters have long been associated in terms of obesity or 
malnourishment. Previous research indicates that any dietary effects on sperm 
parameters for those with a healthy BMI are often due to a deficiency in minerals 
and/or vitamins such as zinc, which is heavily implicated in male infertility. Abbasi 
et al, (1980) demonstrated a significant (p<0.05) reduction in total sperm count 
following restriction of zinc to 2.7-5.0mg daily for a 24-40 week period. Interestingly, 
total sperm count returned to the baseline level 6-12 months following intervention.  
Datillo et al (2014) demonstrated that a 4-month period of daily supplementation 
with multivitamins (B vitamins, vitamin E, zinc) resulted in 18 (21%) spontaneous 
pregnancies & births in couples with ≥2 failed assisted reproductive technology 
(ART) attempts. Compounds derived from plants such as genistein, present in soya 
are demonstrated to have a negative effect upon sperm count and motility, in 
addition to playing a role in an aberrant transcriptome in testicular germ cells 
(Mendiola et al, 2010). Veganism (a restrictive diet absent of all animal products) is 
becoming increasingly popular over a traditional omnivorous diet for a variety of 
social, economic and environmental reasons (section 1.2).  
In this study, no significant relationship was established between the sperm 
parameters and diet choice (Figure 11). There are many cofounding factors that 
could affect this such as the multivitamin supplements self-reported by the entire 
vegan cohort compared to none of the omnivorous cohort. Not all confounding 
factors are easily identifiable as levels of vitamins and minerals were not measured 
in this study and therefore could not be accounted for. Any study investigating diet 
is extremely variable as caloric intake, macronutrient levels, time that meals are 
eaten, and fasted periods could all affect results. 
Further research is necessary to thoroughly investigate any effect diet choice may 
have on sperm parameters.   
4.1.2 Global Methylation 
 
Despite the inability within the field to agree whether global methylation is a direct 
measure for infertility or not, it is nevertheless a useful, cost effective measurement 
of total DNA methylation when searching for novel candidate genes for investigation. 
Vitamin B12 is a dietary compound which is essential to the methylation process. 
B12 assists in the re-methylation of homocysteine to methionine, which in turn 
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combines with ATP to form S-adenosylmethionine; the primary methyl donor in the 
methylation process (section 1.3.2.1). B12 is normally deficient in vegan diets, which 
could potentially result in hypomethylation due to the lack of methyl donor 
production.  
There was no statistically significant difference in levels of 5-methylcytosine% 
between the vegan cohort and omnivorous cohort (p=0.1954). This could potentially 
be due to B12 supplementation of the entire vegan cohort and no supplementation 
of the omnivorous cohort. However, this could not be controlled for and was not 
possible to measure or account for supplementation via any other method except 
the food frequency questionnaire (Appendix 7.6).   
 
4.1.3 Evaluation of Potential Cofounding Factors from Biometrics and 
Lifestyle 
 
A food frequency questionnaire was used primarily to assess whether participants 
were following their self-reported diet (vegan, omnivorous), quantify weekly alcohol 
unit intake, weekly exercise and biometrics.  
This approach can come with caveats with limitations to self-reporting; accurate 
memory of events decreases with time, the requested information is usually 
inaccurately reported, increasing age also increases the inaccuracy of self-
reporting. Education level also affects accuracy of self-reporting, those with a higher 
education provided more accurate information than those without (Short et al, 2009).  
This adds further confounding factors; however, the participants were only asked to 
recall the previous 3 months, and of the cohorts none of the participants were of 
advanced age, therefore dietary recall can be considered relatively accurate. 
In order to exercise more control and minimise confounding factors, participants 
could be asked to follow strict calorie-matched diet plans using a food diary or food 
tracker mobile app. Alternatively, to maintain an observational approach, vegan and 
omnivorous cohorts could be further subdivided into lacto-omnivorous, lacto-ovo-
omnivorous, vegan, raw-vegan etc and diets and caloric intake tracked via food 
diary or food tracker mobile application in order to pinpoint which foods, if any, have 
an effect upon the epigenetic signature of sperm DNA. 
Furthermore, compounds involved in the methylation process such as 
phytoestrogens, B12, zinc, were not directly measured in this research. The level of 
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compounds was assumed on the basis of self-reporting in the food frequency 
questionnaire and dietary subscription, vegan diets are generally deficient in B12 
due to the lack of meat, and high in phytoestrogens due to the adoption of soya as 
a dairy alternative, and vice versa in omnivorous diets. For example, questionnaire 
data demonstrated that all 5 vegan participants consumed soya products on at least 
a weekly basis, whilst none of the 5 omnivorous participants consumed soya, 
research has previously indicated that soy isoflavones can have an effect on 
methylation by reactivating methylated genes partially via direct DNA 
methyltransferase inhibition (Fang et al, 2005).  
Measuring of such compounds within the blood and semen would assist in the 
quantification, and correlation with methylation data. 
Despite this, when analysing the potential confounding factors in the cohorts of 
vegan and omnivorous diet choices, the biometrics and lifestyle factors were not 
statistically significant and therefore did not need accounting for in further analysis 
(section 3.1.3).  
 
4.2 Part 2 – Investigation of global methylation and sperm parameters 
and lifestyle and biometrics 
 
4.2.1 Sperm parameters and global methylation 
 
Sperm parameters are a useful tool for assessing fertility. Due to debate in the field 
about how accurate global methylation of total sperm DNA is as a predictor of 
infertility. This study used correlation analysis to investigate the relationship 
between global methylation of total sperm DNA and sperm parameters which would 
have given an indication as to whether this study found global sperm methylation to 
be related to other parameters that are implicated in male infertility. This study found 
that global methylation was not correlated to any of the sperm parameters, this is in 
line with previous studies suggesting the same (Nevin and Carroll, 2015). 
 
4.2.2 Lifestyle and biometrics 
 
Diet has often been implicated in reproductive health, particularly in the case of an 
abnormal BMI. A BMI of  >30kg/m2 (obese) or <18.5kg/m2 (underweight) as defined 
by WHO (World Health Organisation, 2018) contributes to poor reproductive 
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outcomes (Qin et al, 2007; Ramlau-Hansen et al, 2007; Zain and Norman, 
2008;Gaskins et al, 2015). Obesity is associated with hypogonadism and further 
disrupts the HPG axis negatively affecting both male and female fertility (Chambers 
and Anderson, 2015; Corona et al, 2015). Obese women respond poorly to assisted 
reproductive technologies (Kasum et al, 2018), have increased complications during 
pregnancy, increased miscarriage, increased blood pressure, increased incidence 
of gestational diabetes as well as larger foetus’ which can lead to complications 
during parturition (Poston et al, 2016). Obesity in males disrupts the HPG axis and 
is associated with poor sperm parameters (Du Plessis et al, 2010). Studies have 
demonstrated increasing prevalence of low progressively motile sperm with 
increasing BMI, in addition to a positive correlation between BMI and 
oligozoospermia (Hammoud et al, 2008b). Petersen et al (2018) observed a 
significant increase in sperm DNA fragmentation and percentage mitochondrial 
membrane potential damage with increasing age. However, in the cohort of males 
with both vegan and omnivorous diets that were used in this pilot study the BMI was 
within the normal range and sperm parameters were all non-significant. 
 
4.3 Part 3 – Investigation of the impact of lifestyle on sperm parameters 
and their interaction 
 
4.3.1 Sperm parameters and lifestyle 
 
This study found no correlation between sperm parameters and lifestyle and 
biometrics (section 3.3.1). This is potentially due to the chosen cohort being selected 
for normozoospermia. All participants lead relatively healthy lifestyles, their BMI was 
normal, alcohol intake was not above the recommended average, they did not 
smoke, all (except one) were sufficiently active and none of the participants were of 
advanced age. 
4.3.2 Dependence of sperm parameters 
 
Progressive motility and sperm concentration were positively correlated in the 
combined cohort, as was progressive motility and vitality, this is in agreement with 
what is well established in previous literature. This is a useful result as it indicates 
that despite the small sample size the cohort seems to still be relatively 
representative of the average population due to the data’s predictable behaviour.  
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4.3.3 Independence of lifestyle and biometrics  
 
There was no significant correlation between any of the lifestyle and biometric 
factors. This indicates that the lifestyle and biometrics were not confounding factors 
and therefore did not need accounting for in the statistics.  
4.4 Limitations 
 
Limitations of sample size (n= 5 for vegans; n= 5 for omnivores) may have biased 
these data. Interestingly, the vegan cohort showed a much higher variation of 
percentage total DNA 5-methylcytosine  than the omnivorous group (range of 4.06 
5-methylcytosine% in total DNA, n=5 and 0.94 5-methylcytosine% in total DNA, n=5, 
respectively) (Figure 12). Further research should be conducted within a larger 
cohort to confirm disparities between 5-methylcytosine% range in between dietary 
exposure groups. Due to the reliance on the self-report method, it was difficult to 
assess any nutrient deficiencies, furthermore, caloric intake was not tracked. 
All the participants recruited on to this study had normozoospermic semen 
parameters (count, concentration, motility and vitality) according to WHO guidelines 
(WHO, 2010) however, their fertility could not be confirmed as none of the 
participants had confirmed offspring.  Per the questionnaire, it was confirmed that 
none of the 10 participants had any children, nor were they actively attempting to 
conceive, therefore had no proven fertility status.  
This research comprises a predominantly white demographic of volunteers. Hsuing 
and colleagues observed a 1.26% (p=0.03) higher global methylation levels of 
leukocyte LINE-1 in non-Caucasians compared to Caucasians (Hsuing et al, 2007). 
Zhang and colleagues demonstrated a 2.2% reduction in mean global methylation 
of LINE-1 in non-Hispanic Blacks, and 1.3% reduction of leukocyte LINE-1 
methylation in Hispanics when compared to non-Hispanic Whites (Zhang, 2011). 
Recruitment of exclusively Caucasian participants in this particular research 
eliminates the confounding factor of these racial disparities in methylation described 
by Zhang (2011), however may limit extrapolation of results to any racial group other 
than Caucasian. 
Sample size (n=10) may have also occluded the extrapolation of results to the 
general population. Larger sample size, a longitudinal approach and measurement 
of additional genes involved in spermatogenesis and methylation would assure 
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more validity. A control group of healthy, normozoospermic males and a group of 
those attending fertility clinics may give a clearer indication as to whether fertility 
status has any effect upon the sperm methylome, and therefore whether aberrant 
epigenetics play a role in idiopathic infertility. 
The analysis of a single sample per participants provided a snapshot of the current 
effect of recent dietary exposure upon sperm parameters and total 5-Methylcytosine 
and was practical given the timescale of this research. Collection and analysis of 
multiple samples at 3-month intervals would provide a transient perspective upon 
the effects of diet upon the sperm methylome over 3 cycles of spermatogenesis 
(perhaps with recruitment of participants undergoing a change in diet from 
omnivorous to vegan).  
4.5 Further Research 
 
Whilst results of methylation analysis were not significant. This pilot study warrants 
further exploration into the relationships between dietary exposures and the sperm-
specific methylome; including potential subsequent implications of diet upon fertility 
and offspring health as a transgenerational consideration.  
Initial experimental design included investigation into the methylation status of 
specific CpG sites within promotor regions of sperm and methylation specific genes; 
DAZL (Deleted in azoospermia-like) and MTHFR (methylenetetrahydrofolate 
reductase), in addition to quantification of 5-methylcytosine as a marker of global 
methylation. Following optimisation, PCR products were obtained for the regions of 
interest for subsequent use in pyrosequencing analysis, however repeated 
contamination diminished the validity of the experiment. These results were 
anticipated to correlate with the differences in 5-methylcytosine% and confirm the 
role of diet as a modifier of methylation, and would certainly be an interesting future 
avenue of research.  
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5.0 Conclusion 
 
Differences in sperm parameters and global methylation between dietary cohorts 
were assessed. No significance was found, only larger variation of 5-
methylcytosine% within the vegan cohort (range of 4.06, n=5), than that of the 
omnivorous cohort (range of 0.94, n=5). This indicates that perhaps the sperm 
methylome of those following a vegan diet may be more heterogenous than the 
sperm methylome of those following an omnivorous diet. 
Correlation between sperm parameters (within the combined cohort, disregarding 
dietary subscription) was demonstrated, however this is not a new finding within the 
field. Progressive motility and sperm concentration were found to be significantly 
positively correlated (r=0.7766, p=0.0082). The progressive motility and vitality were 
also significantly positively correlated (r=0.6535, p=0.0404). 
This project aimed primarily to investigate potential differences in sperm global 
methylation levels, in addition to sperm count, concentration, motility and vitality, 
between those adhering to an omnivorous diet or a vegan diet.  
Based upon results of this pilot study, it can be concluded that diet has no effect 
upon sperm parameters or the sperm methylome.  
The paucity of research in this particular area necessitates further investigation. 
Future research designed with the considerations described in the discussion must 
be conducted in order to better elucidate any differences between the sperm 
methylation status of those subscribing to a vegan or omnivorous dietary pattern, 
and whether either an omnivorous or vegan diet confers a methylome beneficial to 
fertility status and offspring health. 
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7.0 Appendices 
7.1 Somatic Cell Removal  
 
As mentioned in section 2.5.3.1, during optimisation of somatic cell removal, sperm 
were exposed to 2 techniques; density gradient centrifugation, and somatic cell lysis 
using detergent. This was to determine a suitable technique capable of total round 
cell removal, to then use on the experimental samples.  
Samples for this purpose were procured per section 2.1.  
Following liquefaction, the fresh sample was centrifuged at 300g for 10 minutes in. 
The pellet was then re-suspended in 2ml phosphate-buffered-saline (PBS) pre-
warmed at 37°C. 
Baseline sperm count was assessed via a haemocytometer count and round cells 
counted according to WHO procedures (WHO, 2010). 
The remainder of the sample was divided equally into 2x clean falcon tubes 
(Corning™Falcon™), pending exposure to the 2 sperm isolation techniques. 
Density gradient centrifugation was performed as described in section 2.5.3.2.  
Sperm and round cells were counted using a haemocytometer, according to WHO 
guidelines (WHO, 2010). 
 
7.1.2 Somatic Cell Lysis Detergent  
 
5x106 sperm were added to the following 8 conditions and incubated on ice for the 
indicated timepoints (Table 16).  
After the indicated time had passed, the samples were immediately centrifuged at 
300g for 3 minutes. The supernatant was discarded, and re-suspended in 100µl 
PBS. Sperm and round cells were counted using a haemocytometer, according to 
WHO guidelines (WHO, 2010). 
 
Table 14 Original baseline concentration of sperm and round cells (x106) post-wash counted using a 
haemocytometer following WHO guidelines (WHO, 2010). 
Baseline Concentration of Sperm & Round Cells Post-Wash (x106/ml) 
Sperm Round Cell 
50.5 1.6 
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Table 15 Concentration of sperm and round cells post-density gradient centrifugation (x106/ml) counted using 
a haemocytometer following WHO guidelines (WHO, 2010). 
. 
Concentration of Sperm & Round Cells Post-Density Gradient Centrifugation (x106/ml) 
Sperm Round Cell 
21.7 0 
 
Table 16 Concentration of sperm and round cells (x106) post-detergent treatment using increasing 
concentrations of Triton-X detergent with phosphate buffered saline control. Counted using a haemocytometer 
following WHO guidelines (WHO, 2010). 
 
Concentration of Sperm & Round Cells Post-Somatic Cell Lysis Buffer Treatment with Increasing Concentrations of 
Detergent at Increasing Exposure Times (x106/ml) 
Concentration of Triton-X detergent used 
Incubation 
Time 
(Min) 
0% Triton-X  
(PBS Control) 
0.05% Triton-X 0.1% Triton-X 0.5% Triton-X 
Sperm 
Round 
Cell 
Sperm Round Cell Sperm Round Cell Sperm 
Round 
Cell 
5 13.75 2.3 21.6 1.5 21.03 0.8 14.98 0.4 
30 20 0.9 23.35 1.2 14.45 0.3 12.22 0.2 
 
Total removal of round cell population (0x106/ml) demonstrated in the density gradient 
centrifugation condition (Table 15). Therefore this method was used in the methodology. 
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7.3 Participant Information Sheet 
 
  
 63 
7.4 Participant Informed Consent Sheet 
 
 
 
  
 Participant informed consent.                             ID code …………………………… 
Name: …………………………………………………  
 
Date of Birth: …………………………………  
 
Project title:  
 
Investigating the effect of diet choice on human sperm. 
 
Principal Investigator:  
Dr Michael Carroll 
 
Investigator/Collaborators:  
Dr Stephane Berneau 
Dr Christopher Murgatroyd 
Dr Andy Povey (external collaborator) 
Prof. Daniel Brison (external collaborator) 
 
 Ethics approval number:  SE1617127 (v.1) 
I have read and understood the information sheet and all verbal explanation outlining the purpose of the study 
and the assessments involved.  
Any questions I have about the study, or my participation in it, have been answered to my satisfaction. I 
understand that I do not have to take part and that I may decide to withdraw from the study at any point without 
having to give a reason. I understand that my sperm will not be used, at any time, for any form of assisted 
reproductive technique, such as fertilising human eggs or the creation of human embryos. I understand that my 
semen may be also used for teaching purposes. I also understand that no personal identifying information will 
be attached to any data derived from this sample and all data presented or published will be anonymised.  
My concerns regarding this study have been answered and such further concerns as I have during the time of 
the study will be responded to. It has been made clear to me that, should I feel that my rights are being infringed 
or that my interests are otherwise being ignored, neglected or denied, I should inform the Chair of the Ethics 
Committee of the School of Healthcare Sciences, Manchester Metropolitan University, Oxford Road, 
Manchester, M1 5GD. 
 
• I give my consent for semen collected from me during the course of this study to be stored at -80°C at MMU 
and used for retrospective biochemical and molecular biology analysis in this study. 
 
(please circle) YES  NO 
• I give my consent for blood collected from me during the course of this study to be stored at MMU for 
retrospective biochemical and molecular biology analysis  
(please circle) YES  NO 
• I give my consent for samples to be donated to MMU for use in this study and afterwards for future 
scientific / medical research and/or teaching purposes. I understand that my sample will not be used 
for any reproductive activities.  
 (please circle) YES  NO 
Signed   …………………………………………..   Date  ………………………………………… 
Name (Print)……………………………….. 
 
Witnessed ……………………………………. Date …………………………………………….. 
Name (Print) ………………………………….  
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7.5 Medical Screening Questionnaire 
 
 
  
Medical Screening Questionnaire SE1617127 (v.1)        Participant code:  
 
It is important that the investigators are aware of any health conditions before participation in 
this research study. This information will be kept strictly confidential.  
 
Date of Birth: _________ 
 
Please answer the following questions as accurately as possible. 
 
Are you currently taking any prescribed medication?   YES/NO 
 
Are you currently attending your GP?     YES/NO 
 
Do you smoke cigarettes / e-cigarettes?        YES/NO 
If yes, how many per day? ______ 
 
Have you ever suffered from a cardiovascular problem?   YES/NO 
i.e. high blood pressure, anaemia, heart attack etc  
 
Have you ever suffered from a neurological disorder?   YES/NO 
i.e. epilepsy, convulsions etc         
          
Have you ever suffered from an endocrine disorder?    YES/NO  
i.e. diabetes etc     
            
   
Have you ever suffered from a chronic gastrointestinal disorder?  YES/NO 
i.e. Crohn’s disease, irritable bowel syndrome etc      
          
Have you ever suffered from a skin disorder?    YES/NO 
i.e. eczema etc          
           
Do you suffer from any allergies?      YES/NO  
i.e. any medications, foods etc  
            
      
Have you had a vasectomy or any urological surrey?   YES/NO 
i.e. testicular surgery   
 
Have you had Mumps?       YES/NO  
 
Have you had any testicular injuries / torsions?     YES/NO 
 
    
Do you knowingly have, or had a Sexually Transmitted Infection?  YES/NO 
           
 
If you have answered “yes” to any of these questions, please provide details below: 
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7.6 Food Frequency and Lifestyle Questionnaire  
 
 
 
                                                      Donor ID 
 
 
 
 
 
 
 
 
 
 
This study has been set up to investigate what factors may affect male fertility.  Please work 
through the questionnaire filling in each question that applies to you, by ticking (✔ ) the box 
or by writing in the space provided. 
 
 
 
 
  
 
Date questionnaire filled in:       day     month     year 
 
 
 
 
 
 
Please complete the details above, then turn over and answer the following questionnaire. This 
questionnaire will ask information concerning environmental, diet, lifestyle exposures, which will 
include some sensitive personal and lifestyle questions such as sexual abstinence and drug use. 
  
If you decide not to answer a question – please cross the question with a line (this will inform the 
researcher that the question was not missed accidently). 
Please read the questions carefully and give attention to the bold words. Answering this questionnaire 
should take about 10-20 minutes. Most of the questions have YES or NO answers, or questions where 
you need to tick a box ✔ or write a number or a word. There is one question about your job where we 
will ask you to answer in detail. 
 
Diet and lifestyle Study  
Sperm Quality 
Questionnaire 1 
 
Diet and lifestyle Study  
Sperm Quality 
Questionnaire 1 
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General questions: 
 
Age 
1.  What is your date of birth?    day                month                 year     
 
 
2. What is your height and your weight now? (material available &in the room if 
necessary) 
 
Height                cm            or                    feet                    inches                            
Weight                Kg           or                    stones                ounces 
Ethnicity 
 
3. Which ethnic group do you consider you belong to? 
 
 White  British                                                Indian  
 
             Other White Background,  Please describe ________________             Pakistani 
 
 Black-Caribbean                                      Bangladesh 
 
 Black-African                Malaysian 
 
 Other Black Background, Please describe _________________           Chinese  
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             Other Ethnic Group, Please describe ___________________ 
 
 
4. Are you … 
  
             Married                                                          In relationship 
 
 Single                 Widower 
 
             Divorced                                                        Other 
 
 
5. Do you have any children?     
 
                                           Yes                     No 
 
 
6. Are you attempting to conceive a baby? 
 
                                           Yes                     No 
 
 
7. Have you ever had your semen analysed? 
 
                                           Yes                     No 
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Your job during the last three months: 
 
 Please write in the table in the next page the type of work you have done in your job during the last three months, please, if you have been in two or more 
jobs during the last three months, mention all of them. To help you, we have given some examples of what other men have written in a previous study. 
Please answer this question even if you were not exposed to any hazard in you job (for example office job). 
 
Examples Job Title Type of company 
(what did they do) 
During the last three months, What were the main 
tasks you did in your job? And what were the 
hazards (chemicals, radiation,....) you were exposed 
to (if applicable)? 
Type of 
job (full 
or part 
time) 
Did you have to wear 
any sort of personal 
protection during your 
job 
 
 
1 
 
Telephone 
account 
manager 
 
 
 
Airline 
 
 
Meetings with clients over telephone, lots of sitting 
down. 
 
 
Full-time 
 
 
None 
 
 
2 
 
 
Sales assistant 
 
 
Garden centre 
(Gardening) 
 
 
1- Selling pesticides, weed killers, fertilisers. 
2- Making up pesticides, weed killers, fertilisers for use 
in garden centre. 
3- Cleaning up spillage.  
 
 
 
Part-time 
 
 
 
Protective clothing, 
respirator, gloves, 
coverall 
 
 
3 
 
 
Pipefitter 
 
 
Plumbing firm 
 
Installing industrial pipe work, gas, water, steam, 
compressed air and this includes soldering. 
Currently I use flux which is lead free solder. 
 
 
 
Full-time  
 
 
None 
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4 
 
 
Electrical 
engineer  
 
 
Nuclear power planet  
 
Executing, evaluating, delivering and managing 
complex engineering and / or cross functional tasks or 
programmes of work, recognising stakeholder and 
customer requirements. 
                                                                                                                                                                                                             
 
Full-time 
 
Protective clothing, 
gloves…… 
 
5 
 
Researcher   
 
University  
 
 
Working in the lab and dealing with chemicals and 
biological materials. 
 
Full-time  
 
Protective clothing, 
gloves 
 
6 
 
 
Decorating 
 
 
 
Domestic decorating 
 
1- Wallpaper decorating: I used adhesives, fillers, putty. 
2- Painting: oil paint, white spirit. 
3- Decorating involves lacquers and silicones. 
 
 
part-time 
 
 
 
Gloves 
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Please complete the table below and write as much as details to describe your jobs in the last three months. 
 
 
 
If you had more than 
one job during the last 
three months, please 
mention all of them 
Job Title Type of company 
(what did they do) 
During the last three months, What were the main 
tasks you did in your job? And what were the 
hazards (chemicals, radiation,....) you were exposed 
to (if applicable)? 
 
Full or part 
time 
Did you have to wear any sort 
of personal protection during 
your job 
    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 During the last 3 months, at your job and/or at home, have you worked with, or 
been exposed to any of the chemicals or physical agents in the table below?  
 
Chemicals or Physical agents at 
job/home 
Please put ✔ in shaded 
boxes for 
Yes or NO 
Yes    
      ✔ 
 
No 
✔ 
Metal Dust or Fumes 
  
Pesticides     
Weed killers (herbicide)   
Fertilisers    
Oils or Greases 
   
Detergents or Soaps (at job only) 
   
Glues, Adhesives or Resins (for example, 
decoration) 
   
Paints, Varnishes or Lacquers 
   
Printing Inks or Dyestuffs 
   
Dry Cleaning Fluids 
   
PVC or plasticisers (at job only)    
Other Solvents (at job only)  
(For cleaning, degreasing, thinning, 
lubricating,  mixing, etc.) 
  
Extremely Hot Environments (at job, 
Sauna, bathing in hot water for long time) 
  
Heavily Vibrating Machinery, 
Equipment or Vehicles 
  
 2 
Non-Ionizing Radiation  
(microwaves, lasers, or high voltage electrical power) 
  
 
 
Health 
 Have you ever had x-rays?                                                          Yes                 No 
 
 
7.1.  If yes, was it for the pelvic region?                                      Yes                 No 
 
 
8. Have you ever had chemotherapy?                                               Yes                 No 
 
 
9. In the last 3 months, have you had any fever or flu?    Yes                 No 
 
 
9.1.  If yes, how long did it last?                  Days 
     
  
10. In the last 3 months, have you had any illnesses?                       Yes                 No 
     11.1. If yes, how would you describe this illness?                 Please tick             
A) Breathing or lung problems.                                                                                       
 B) Skin problems.                                                                                                                                                                                           
 C) Hearing problems.                                                                                                                       
 D) Stress, depression or anxiety.                                                                                                                                                                                    
 E) Headache and/or eyestrain.                                                     
 F) Heart disease / attack, other circulatory system.                            
 G) Infectious disease (virus, bacteria).                                              
 H) Bone, joint or muscle problems which mainly affect: 
     H1) Arms, hands, neck or shoulder.                                                      
     H2) Hips, legs or feet.                                                                                                                 
 3 
     H3) Back.                                                                                                           
    I) Other, please specify:     
 
 
    11.2. Were any of these made worse by your work?                               Yes                     No  
 
 
11. In the last 3 months, have you used any medications?                         Yes                    No 
 [such as antibiotics, pain killers, antihistamines etc] 
 
11.1. If yes, please specify: 
[name of medicine, dose and duration (if known)] 
 
12. Do you currently have a varicocele?                                     Yes                No               Don’t Know 
(A varicocele is a medical condition when 
 veins become enlarged inside the scrotum) 
 
12.1. If No, Have you ever had a varicocele?       Yes                No           
 
 
Lifestyle 
 
13. Smoking 
 
Are you :                                                                                          please tick  
                                                                                                All appropriate answers 
 
A current smoker (at least one cigarette per day) 
 
Currently using e-cigarettes  
  
An ex-smoker                                
 
A non-smoker (never smoked) 
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If you are a current smoker, please answer questions 14.1             14.3 then go to question 15 
 
If you use e-cigarettes, please answer questions 14.4            14.6 then go to question 15 
 
If you are an ex-smoker, please answer questions 14.7          14.14 then go to question 15  
  
If you are a non-smoker, please answer questions 14.11        14.14 then go to question 15   
 
If you are a current smoker 
13.1. What do you smoke? (please tick the boxes for all that apply) 
 
                 Cigarettes                   hand rolled cigarettes                    cigars                       pipes 
 
  
                 Other     please specify: ………………………………   
 
 
13.2. How much do you smoke a day on average (cigs/day, oz/day,other…)? 
  
     _______________________________________________________ 
 
 
13.3. At what age did you start smoking regularly?      ______________________ 
 
 
If you use e-cigarettes 
13.4. How often do you currently use an e-cigarette? (Please tick only one box) 
 
          Daily                          Less than daily, but at least once a week 
 
          Less than weekly, but at least once a month                  Less than monthly  
 
 
13.5. If daily, on average how many times per day do you use an e-cigarette?                   
 5 
 
13.6. At what age did you start smoking regularly?      ______________________ 
 
If you are an ex-smoker 
13.7. What did you smoke? (Please tick the boxes for all that apply) 
 
                Cigarettes                     hand rolled cigarettes           cigars                       pipes 
 
                Other    please specify: ……………………………………….   
 
13.8. At what age did you start smoking regularly      ______________________ 
 
13.9. At what age did you stop smoking?            ____________________ 
 
13.10. How many cigarettes (etc) did you smoke a day on average (cigs/day, oz/day,other…) 
 
                 ____________________________________________________________ 
 
If you are an ex-smoker or non-smoker 
13.11.  Are you exposed to cigarette smoke of other smokers                  Yes                   No 
       at home, work, club…?  
 
If yes: 
13.12.  During the last three months, How many hours a week (on average)  
have you been exposed to the cigarette smoke of other people?                                                    hours 
 
 
13.13.  Are you exposed to e-cigarette vapor of others at  
         home, work, club…?                                                                                         Yes                              No  
 
If yes: 
13.14. During the last three months, How many hours a week (on average)  
have you been exposed to the e-cigarette vapor of other people?                                                   hours 
 
 
Drinking Alcohol: 
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14.  Do you drink alcohol regularly?                                        Yes               No  
      (at least one drink per week) 
 
If yes: 
14.1. During the last three months, how much alcohol did you consume on average every week 
(please write a number in the boxes when applicable)? 
 
 
           Pints of Lager                           Pints of Beer                          Measures of spirits (singles) 
 
                          
           Bottles of alcopops                  Glasses of wine                      Measures of fortified wines                                  
           (WKD, Smirnoff Ice…)                                                                     (Port, Sherry, Martini …) 
 
   Other, please specify  
 
 
 
Drug consumption: 
15. Have you ever consumed a recreational drug?                   Yes                   No 
 
15.1.  If yes, which of the following drugs have you used in the past year: 
 
             Methamphetamines (speed, crystal)                      Cocaine 
 
             Cannabis (marijuana, pot)                                      Narcotics (heroin, oxycodone, methadone, 
etc) 
 
             Inhalants (aerosol, glue)                                         Hallucinogens (LSD, mushrooms) 
 
             Tranquilizers (valium)                                            Other (please specify ………………….) 
 
 
15.2. How often have you used these drugs?            Monthly             Weekly             Daily 
or almost daily 
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16.  Have you consumed a recreational drug in the last 3 months?                      Yes                   No 
 
16.1.  If yes, which of the following drugs have you used: 
 
             Methamphetamines (speed, crystal)                      Cocaine 
 
             Cannabis (marijuana, pot)                                      Narcotics (heroin, oxycodone, methadone, 
etc) 
 
             Inhalants (aerosol, glue)                                         Hallucinogens (LSD, mushrooms) 
 
             Tranquilizers (valium)                                            Other (please specify ………………….) 
 
 
Clothing: 
17. Do you usually wear underwear?                             Yes                  No 
 
17.1.  If yes, Please indicate the style of underwear you typically wear (tick all that are 
appropriate) 
c 
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17.2.  At night, do you usually wear underwear?               Yes                  No 
 
Exercise: 
18.  In a typical week, how many times did you do the following kinds of exercise for more than 
15 minutes? And how many hours (in total) per week? 
 
18.1. Strenuous exercise                                                                                    Times                         
Hours                                              
(such as swimming laps, aerobics, calisthenics, running, jogging,  
basketball, cycling on hills or faster than 12mph, and racquetball)                         
 
18.2. Moderate exercise                                                                                    Times                         
Hours                                                                                                                                 
 (such as brisk walking, golf, volleyball, cycling on level streets, 
 recreational tennis and softball)                                                                         
 
18.3. Mild exercise                                                                                             Times                         
Hours                                              
  (exercise which requires a minimum of effort, such as                                                                       
slow walking, billiard, croquet, putting away groceries)                                          
 
19. during your leisure-time, how many hours did you do  
strenuous activity for long enough to work up a sweat                                        Times                         
Hours                                             (so that your heart beats rapidly)?  
 
Dietary Supplements: 
20. In the last 3 months, have you taken dietary or exercise supplements 
      (Including protein shakes)?                                                                               Yes                No 
 
If Yes, Please indicate which of the below are being used and how often 
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Whey Protein                   Yes                       No                  How many Days per Week  
 
 
Pea Protein                       Yes                       No                  How many Days per Week 
 
 
Hemp Protein                    Yes                      No                  How many Days per Week 
 
 
Soy Protein                       Yes                       No                  How many Days per Week 
 
 
Brown Rice Protein          Yes                       No                  How many Days per Week 
 
 
Other Protein                    Yes                       No                  How many Days per Week 
 
 
Creatine                             Yes                      No                  How many Days per Week 
 
 
Zinc                                   Yes                       No                 How many Days per Week 
 
 
Selenium                           Yes                       No                 How many Days per Week 
 
 
Arginine                            Yes                       No                 How many Days per Week 
 
 
Carnitine                           Yes                       No                  How many Days per Week 
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Calcium                            Yes                        No                 How many Days per Week 
 
 
Vitamin C                         Yes                        No                 How many Days per Week 
 
 
Vitamin D                         Yes                        No                 How many Days per Week 
 
 
Vitamin E                          Yes                        No                 How many Days per Week 
 
 
Vitamin B6                        Yes                       No                  How many Days per Week 
 
 
Vitamin B12                                  Yes                       No                  How many Days per Week 
 
 
Multivitamins                   Yes                      No                 How many Days per Week 
 
 
Glutathione                        Yes                      No                 How many Days per Week 
 
 
Lutein                                 Yes                      No                 How many Days per Week    
 
Diet: 
21. How would you describe your diet during the last three months? 
 
                Vegan                                                Meat eater                                       Pescetarian 
 
 
                Vegetarian                 Meat and fish eater                          Other 
…………….. 
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21.1.  Would you describe your diet as: 
 
                Raw (not boiled)                                Plant-based                                       Fruitarian only 
 
 
                Dairy-free                                          No egg                                              No honey 
 
 
               Wheat-free                                         Gluten-free                                        None of these 
 
21.2.  How long have you been following this diet?  …………………………………….…… 
 
21.3.  Have you been previously been vegetarian or pescetarian?                Yes                     
No 
 
21.4.  If yes, please specify diet and how long have you followed this diet? 
 
Previous diet: …………………………………………………………… 
 
Duration: ……………………………………………………………...… 
 
22. On average, how many portions of FRUIT do you eat a day? 
(examples include a handful of grapes, an orange, a glass of fruit juice, a handful of dried fruit) 
 
 
23. On average, how many portions of VEGETABLES do you eat a day? 
(examples includes 3 heaped tablespoons of carrots, a side salad, 2 spears of broccoli) 
 
 
24. On average, how many times do you eat per day? 
(examples, breakfast, lunch, diner, afternoon tea, snacks) 
 
24.1. Please describe briefly your typical daily diet: 
(example, “no breakfast” but lunch and dinner with 2 snack breaks) 
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25. Please answer the following questions (Table in the next page) about what you usually eat 
and drink. Although the list looks a little bit long, it should not take more than 10-15 minutes 
to complete. Please read the instructions below. 
 
 Please tick (Never) column if you have not eaten the food during the last three months. 
 If you tick the wrong box by mistake or you want to change your answer, please put a     on the 
wrong answer and a ✔in the right box. 
 In the last column (“How much do you normally eat per serving?”), you can answer by using the 
number of unit or number of pieces. For example, 3 apples, 5 tablespoons, 3 sausages, 2 cup of 
tea, 1 bottle (500ml) of orange juice, 1 pint of milk, 5 slices of bread or toast, large, medium or 
small serving of broccoli, chicken, beef, …….  . 
 
 
 
 
FOODS 
 
 
How many times did you eat or drink these foods in 
THE LAST THREE MONTHS? 
 
 
 
How much do you 
normally eat per 
serving? 
 
 
Neve
r 
Less 
than 
once 
a 
mon
th 
1 – 2 
time
s per 
mon
th 
 
Once 
a 
wee
k 
2 – 3 
times 
per 
week 
4 – 6 
times 
per 
week 
 
Ever
y day 
Chicken or other 
poultry (white 
meat) 
 
     
✔ 
  large, medium or 
small serving 
 
Beef including 
mince 
 
✔ 
   
✔ 
    
250g or large 
serving 
 
 
 
 
 
FOODS 
 
 
How many times did you eat these foods in THE 
LAST THREE MONTHS? 
 
 
How much do you 
normally eat per 
serving? 
Small, Medium or 
Large 
 
 
Neve
r 
Less 
than 
once 
a 
mon
th 
1 – 2 
time
s per 
mon
th 
 
Once 
a 
wee
k 
2 – 3 
times 
per 
week 
4 – 6 
times 
per 
week 
 
Every 
day 
 
Chicken or other 
poultry (white 
meat) 
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Smoked chicken or 
other poultry 
 
        
 
Beef including 
mince 
 
        
 
Beefburgers 
 
        
 
Lamb 
 
        
 
Ham 
 
        
 
Bacon 
 
        
 
Sausage or chorizo 
 
        
 
Hot dogs or 
frankenfurter 
 
        
Liver         
Smoked red meat 
(red meat includes 
beef, lamb, ham, 
bacon,…) 
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Very fried meat, 
barbeque, grilled 
meat (red and white 
meat) 
        
Pizza         
Pizza (veggie or 
vegan) 
        
 
Fish (dried, frozen) 
 
        
Oily fish (fresh or 
canned e.g. tuna, 
salmon, sardines,…) 
  
 
 
      
 
 
 
FOODS 
 
 
How many times did you eat or drink these foods in 
THE LAST THREE MONTHS? 
 
 
 
How much do you 
normally eat per 
serving? 
Small, Medium or 
Large 
 
 
Nev
er 
Less 
than 
once 
a 
mon
th 
1 – 2 
time
s per 
mon
th 
 
Once 
a 
week 
2 – 3 
time
s per 
wee
k 
4 – 6 
times 
per 
week 
 
Every 
day 
 
Fried fish 
 
        
 
Smoked fish 
 
        
 
Oysters 
 
        
 
Shrimps 
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Broiled or grilled 
squid  
 
        
 
Sauerkraut 
 
        
Crisps 
        
 
French fries, fried 
potatoes, chips 
 
        
Spicy food 
(medium/hot) 
        
Vegetable oil         
Olive oil         
Soy flour, 
Soybeans, boiled, 
Tempeh, Soy meat. 
        
Tofu         
Soy Milk         
Almond milk         
Coconut Milk         
Full fat milk 
 
        
 
 
 
 
FOODS 
 
 
How many times did you eat or drink these foods in 
THE LAST THREE MONTHS? 
 
 
 
How much do you 
normally eat per 
serving? 
 
 
Nev
er 
Less 
than 
once 
a 
1 – 2 
time
s per 
mont
h 
 
Once 
a 
week 
2 – 3 
time
s per 
wee
k 
4 – 6 
times 
per 
week 
 
Every 
day 
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mon
th 
Small, Medium or 
Large 
Semi-Skimmed milk         
Skimmed milk         
Dried Milk         
Yoghurt (Low fat)         
 
Yoghurt (Natural) 
 
        
Soy Yoghurt         
Dairy-free Yoghurt         
Cottage cheese 
        
 
Cheese (all types) 
        
Halloumi 
        
Butter / margarine         
Low fat spread or 
half fat ghee 
        
Cholesterol 
lowering spread 
        
Eggs         
 
Orange (fruit, juice) 
 
        
 
Blackberry (fruit, 
juice) 
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Blueberry (fruit, 
juice)  
 
 
Cherry (fruit, juice) 
 
        
 
Elderberry (fruit, 
juice) 
 
        
 
 
 
 
FOODS 
 
 
How many times did you eat or drink these foods in 
THE LAST THREE MONTHS? 
 
 
How much do you 
normally eat per 
serving? Small, 
Medium or Large 
 
 
Nev
er 
Less 
than 
once 
a 
mon
th 
1 – 2 
time
s per 
mont
h 
 
Once 
a 
week 
2 – 3 
time
s per 
wee
k 
4 – 6 
times 
per 
week 
 
Every 
day 
 
Kiwi (fruit, juice) 
 
        
 
Grape 
(black/red/blue) 
            (fruit / juice) 
 
        
Mango (fruit, juice) 
        
Pomegranate (fruit, 
juice)  
        
Strawberry (fruit, 
juice) 
        
Raspberry (fruit, 
juice) 
        
 
Aubergine 
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Onion 
        
 
Kidney Beans, Black 
Beans 
 
        
Butternut & winter 
Squash 
        
 
Asparagus 
 
        
Leek         
Lettuce         
Chinese Cabbage  
        
 
Cabbage (other 
types) 
 
        
Beet red (red beet 
or beetroot) 
        
 
FOODS 
 
 
 
 
 
How many times did you eat or drink these foods in 
THE LAST THREE MONTHS? 
How much do you 
normally eat per 
serving? Small, 
Medium or Large 
 
Nev
er 
 
Less 
than 
once 
a 
mon
th 
1 – 2 
time
s per 
mont
h 
 
Once 
a 
week 
2 – 3 
time
s per 
wee
k 
4 – 6 
times 
per 
week 
 
Every 
day 
Tomatoes         
Carrots         
Broccoli 
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Kale 
        
 
Spinach 
 
        
 
Parsley (dried) 
 
        
Clove 
        
Cumin 
        
Basil 
        
Thyme 
        
Cinnamon 
        
Oregano 
        
Ginger         
Bok choy (Pak choi)         
Chick peas, dried         
Breakfast cereal         
 
Wheat bran  
 
        
Wheat germ (whole 
wheat bread) 
        
 
Biscuits or Cookies  
 
        
 
 
 
How many times did you eat or drink these foods in 
THE LAST THREE MONTHS? 
How much do you 
normally eat per 
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FOODS 
 
 
 
Nev
er 
Less 
than 
once 
a 
mon
th 
1 – 2 
time
s per 
mont
h 
 
Once 
a 
week 
2 – 3 
time
s per 
wee
k 
4 – 6 
times 
per 
week 
 
Every 
day 
serving? Small, 
Medium or Large 
Weetabix Protein 
& other protein 
bars 
        
Sweet potatoes         
Pumpkin seeds         
Sesame seeds         
Multi-grain bread         
 
Bread (other) 
 
        
Pies, cakes and 
puddings 
        
 
Brown Rice 
 
        
White Rice         
Quinoa 
        
Ice cream         
Dark Chocolate         
Cocoa Power 
        
Breakfast tea (cups)         
 
Black tea (cups) 
 
        
 
Green tea (cups) 
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Coffee  
(cups, Not 
decaffeinated) 
        
Coffee 
(cups, decaffeinated) 
        
Coca-Cola (or non 
brand coke) 
Not decaffeinated 
        
Coca-Cola (or non 
brand coke) 
Decaffeinated 
        
 
 
 
 
FOODS 
 
 
How many times did you eat or drink these foods in 
THE LAST THREE MONTHS? 
 
 
How much do you 
normally eat per 
serving? Small, 
Medium or Large 
 
 
Neve
r 
Less 
than 
once 
a 
mont
h 
1 – 2 
time
s per 
mont
h 
 
Once 
a 
week 
2 – 3 
time
s per 
week 
4 – 6 
time
s 
per 
week 
 
Every 
day 
Coca-Cola (or non 
brand coke) 
Low sugar 
        
Other Soda 
        
Other soda 
Low sugar 
        
Red Bull (or non 
brand) 
Not decaffeinated 
        
Other energising  
drink 
        
Walnut 
        
Pecan nuts 
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Peanut 
        
Cashew Nut 
        
Almond 
        
Hummus         
Garlic 
        
Dried Apricots, 
dates and prunes 
        
Yeast (nutritional) 
Such as marmite 
        
26. Where do you get most of your drinking water at home? 
 
                Mains tap                  Bottled            Other eg well  
  
                water        water    or spring 
  
27. How is your milk usually packaged? 
 
                Plastic        Glass 
 
 
                Carton        Other, please state  
 
28. How is your vegetable/olive oil usually packaged? 
 
                Plastic                  Glass                                 Other, please state 
 
 
29. How are your beverages (juices, fizzy soft drink) packaged? 
 
                Mostly glass                 Mostly plastic             Mostly cartons 
 
 
                No packaging                 Can                                    Other, Please state  
 23 
 
Travel: 
30. In the last three months, have you been travelling? 
 
                                           Yes                     No 
 
30.1.  If yes, where about? 
 
              UK                                             Another European country                       North America 
 
 
              South America                           Africa                                                        Asia 
 
               
              Oceania        
 
30.2.  If yes, which of the following modes of transport have you used to travel: 
 
 
              Car                                               Bus                                                        Train 
 
 
              Plane                                            Other, please state ………………………………….          
                                                
 
30.3. If you went outside UK, where did you go? Please specify the duration 
 
                                                                                                     
  
 
                                                                                                                                  
 
Please answer the following questions about the last 24 hours: 
31. Smoking: 
 
31.1.  Have you smoked in the last 24 hours?                              Yes              No 
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31.2. If yes, what did you smoke? (Please tick the boxes for all that apply) 
 
                Cigarettes                     hand rolled cigarettes           cigars                       pipes 
 
                Other    please specify: ……………………………………….   
 
           
31.3.  How much of the above did you smoke (e.g. 5 cigarettes)? 
  Period of Abstin 
  If No, 
31.4.  In the last 24 hours, were you exposed to other                  Yes                    No      
people’s cigarette smoke?               
        
31.5.  If yes, how long were you exposed for?                                                      Hours 
 
32. Use of E-Cigarettes: 
 
32.1. In the last 24 hours, have you used e-cigarettes?                  Yes                   No      
 
 
32.2. If Yes how many times? 
 
 
32.3.  In the last 24 hours were you exposed to other 
                                 people’s e-cigarette vapor?                                   Yes                     No      
 
 
32.4. If Yes for how long?                                                                       
Hours                
                            
33. Have you consumed a recreational drug in the last 24 hours?                   Yes                   No 
 
33.1.  If yes, which of the following drugs have you used: 
 
             Methamphetamines (speed, crystal)                      Cocaine 
 
             Cannabis (marijuana, pot)                                      Narcotics (heroin, oxycodone, methadone, 
etc) 
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             Inhalants (aerosol, glue)                                         Hallucinogens (LSD, mushrooms) 
 
             Tranquilizers (valium)                                            Other (please specify ………………….) 
 
 
              
34. How long have you been abstinent?                                                                       Hours   
 
 
35. Have you provided the semen sample in MMU?                  Yes                           No  
 
             
36. Attendance at Work 
 
4.1. What is your current job title (e.g. Decorator)? 
 
 
4.2. . Have you been at work during the last 24 hours                        Yes             No 
 
4.3. . If 'yes', was this typical of your normal work                             Yes             No 
 
If No, please give more details:  
 
37. In the last 24 hours did you have any of these foods? 
37.1. Chicken or other poultry                                                                Yes                 No 
 
    If yes, please state how cooked (fried, smoked, barbeque, grilled, other …) 
 
 
37.2.  Red meat (beef, lamb, ham, sausages ……)                                   Yes                No 
 
        If yes, please state how cooked (fried, smoked, barbeque, grilled, other …)   
 
 
37.3. Fish                                                                                                   Yes                No   
 
        If yes, please state how cooked (fried, smoked, barbeque, grilled, other) 
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If there is any information about your job, lifestyle, diet or habit that you think may be of 
relevance to this study, please use the space below. 
 
 
 
 
 
 
Many thanks for filling in the questionnaire. 
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